ExlService Holdings Inc
For the period ended Dec 31, 2024. Filed Feb 25, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 25, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Notes to Consolidated Financial Statements
- Organization
ExlService Holdings, Inc. (“ExlService Holdings”) is organized as a corporation under the laws of the State of Delaware. ExlService Holdings, together with its subsidiaries and affiliates (collectively, the “Company”), is a global data and artificial intelligence (“AI”) company that offers services and solutions to reinvent client business models, drive better outcomes and unlock growth with speed. The Company harnesses the power of data, AI, and deep industry knowledge to transform businesses, including the world’s leading corporations in industries including insurance, healthcare, banking and capital markets, retail, communications and media, and energy and infrastructure, among others.
The Company’s clients are located principally in the United States of America (“U.S.”) and the United Kingdom (“U.K.”).
- Summary of Significant Accounting Policies
(a)Basis of Preparation and Principles of Consolidation
The consolidated financial statements have been prepared in conformity with United States generally accepted accounting principles (“U.S. GAAP”). The accompanying financial statements have been prepared on a consolidated basis and reflect the financial statements of ExlService Holdings, Inc. and all of its subsidiaries and includes the Company's share in the results of its associates.
The standalone financial statements of subsidiaries are fully consolidated on a line-by-line basis. Intra-group balances and transactions, and gains and losses arising from intra-group transactions, are eliminated while preparing consolidated financial statements.
The Company’s investments in equity affiliates are initially recorded at cost and any excess purchase consideration paid over proportionate share of the fair value of the net assets of the investee at the acquisition date is recognized as goodwill. The proportionate share of net income or loss of the investee after its acquisition is recognized in the consolidated statements of income.
Accounting policies of the respective individual subsidiaries and equity affiliates are aligned wherever necessary, so as to ensure consistency with the accounting policies that are adopted by the Company under U.S. GAAP.
(b)Use of Estimates
The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the carrying amounts of assets and liabilities and disclosure of contingent assets and liabilities included in the consolidated financial statements. Although these estimates are based on management’s best assessment of the current business environment, actual results may be different from those estimates. The significant estimates that affect the consolidated financial statements include, but are not limited to, estimates of the fair value of the identifiable intangible assets and contingent consideration, purchase price allocation, including revenue projections and the discount rate applied within the discounted cash flow model for business acquisitions, credit risk of customers, the nature and timing of the satisfaction of performance obligations, the standalone selling price of performance obligations, variable consideration in a customer contract, expected recoverability from customers with contingent fee arrangements, estimated costs to complete fixed price contracts, assets and obligations related to employee benefit plans, deferred tax valuation allowances, income-tax uncertainties and other contingencies, valuation of derivative financial instruments and stock-based awards, and useful life of long-lived assets and other intangible assets. The significant assumptions underneath these estimates include, but are not limited to assumptions to calculate stock-based compensation expense, determine incremental borrowing rate to calculate lease liabilities and right-of-use (“ROU”) assets, determine lease term to calculate single operating lease cost, determine pattern of generation of economic benefits to calculate depreciation and amortization for long-lived assets and other intangible assets, and recoverability of long-lived assets, goodwill and other intangible assets.
(c)Foreign Currency Translation
The functional currency of each entity in the Company is the currency of the primary economic environment in which it operates. Transactions in foreign currencies are initially recorded into functional currency at the rates of exchange prevailing on the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are remeasured into functional currency at the rates of exchange prevailing at the balance sheet date. Non-monetary assets and liabilities are remeasured to the functional currency at exchange rates that prevailed on the date of inception of the transaction. All foreign exchange gains and losses arising on re-measurement are recorded in the Company's consolidated statements of income.
The assets and liabilities of the subsidiaries for which the functional currency is other than the U.S. dollar are translated into U.S. dollars, the reporting currency, at the rate of exchange prevailing on the balance sheet date. Revenues and expenses are translated into U.S. dollars at the exchange rates prevailing on the last business day of each month, which approximates the average monthly exchange rate. Share capital and other equity items are translated at exchange rates that prevailed on the date of inception of the transaction. Resulting translation adjustments are included in “Accumulated other comprehensive income/(loss)” in the consolidated balance sheets.
(d)Revenue Recognition
Revenue is recognized when services are provided to the Company's customers, in an amount that reflects the consideration which the Company expect to be entitled to in exchange for the services provided. The Company recognizes revenue when it satisfies a performance obligation by providing services to a customer.
Revenue is measured based on consideration specified in a contract with a customer and excludes value added tax, business tax, any applicable discounts and amounts collected on behalf of third parties. Reimbursements of out-of-pocket expenses are included as a part of revenue.
Nature of Services
The Company derives its revenues from digital operations and solutions and analytics services. The Company provides digital operations and solutions and analytics services helping businesses enhance revenue growth and improve profitability.
Type of Contracts and Basis of Recognition
i. Revenues under time-and-material and transaction based contracts are recognized as the services are performed. When the terms of the client contract specify service level parameters that must be met (such as turnaround time or accuracy), the Company monitors such service level parameters to determine if any service credits or penalties have been incurred. Revenues are recognized net of any penalties or service credits that are due to a client.
ii. Revenues for the Company’s fixed-price contracts, which include business support services provided on a fixed price basis or implementation of applications or solutions, are recognized considering costs incurred to date relative to total estimated costs at completion to measure progress toward satisfying the Company’s performance obligations. Incurred cost represents work performed, which corresponds with, and thereby reasonably reflects transfer of control to the client. The use of this method requires significant judgment to estimate the stage of completion and/or cost required to complete the contracted scope of work, including assumptions and estimates relative to the length of time to complete the project and the nature and complexity of the work to be performed and resources engaged. The Company regularly monitors these estimates throughout the execution of the project and records changes in the period in which a change in an estimate is determined. If a change in an estimate results in a projected loss on a project, such loss is recognized in the period in which it is first identified.
iii. Revenue from the Company’s software and related services contracts, which are not significant, are primarily related to annual maintenance renewals or incremental license fees for additional users. Maintenance revenues are generally recognized on a straight-line basis over the annual contract term. Fees for incremental license without any associated services are recognized at the point in time upon delivery of the related incremental license.
To a lesser extent, certain contracts may include offerings such as sale of licenses, which may be perpetual or subscription-based. The Company recognizes revenue from distinct perpetual licenses upfront at a point in time when the software is made available to the client, whereas for a combined software license and services performance obligation, revenue is recognized over the period that the services are performed.
Revenue from distinct subscription based licenses is recognized over the period of service performed. Revenue from any associated maintenance or ongoing support services is recognized over the term of the contract.
iv. Revenues from payment integrity services having contingent fee arrangements are recognized by the Company at the point in time when a performance obligation is satisfied, which is when it identifies an overpayment claim. In such contracts, the Company’s consideration is contingent upon the actual collections made by its customers and net of any subsequent retraction claims. Based on guidance on “variable consideration” in Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers(“ASC Topic 606”), the Company uses its historical experience and projections to determine the expected amount of revenue to be recognized based on the expected consideration to be received from its customers. Any adjustment required due to change in estimates are recorded in the period in which such change is identified. The estimated amount of revenue to be collected from our customers are presented as contract assets within “Other Current Assets”.
Modification to Contracts
The Company’s contracts may be modified to add, remove or change existing performance obligations. The accounting for modifications to contracts involves assessing whether the services added to an existing contract are distinct and whether the pricing is at a standalone selling price. Services added that are distinct and at standalone selling price are accounted on a prospective basis either as a separate contract, or as a termination of existing contract and creation of a new contract.
Arrangements with Multiple Performance Obligations
The Company’s contracts with customers do not generally bundle different services together except for software and related services contracts, which are not significant, involving implementation services and post contract maintenance services. In such software and related services contracts, revenue is recognized based upon the transaction price allocated to each performance obligation based on the relative standalone selling price.
Allocation of Transaction Price to Performance Obligations
The transaction price is allocated to performance obligations on a relative standalone selling price basis. Standalone selling prices are estimated by reference to the total transaction price less the sum of the observable standalone selling prices of other goods or services promised in the contract. In assessing whether to allocate variable consideration to a specific part of the contract, the Company considers the nature of the variable payment and whether it relates specifically to its efforts to satisfy a specific part of the contract.
Variable Consideration
Variability in the transaction price arises primarily due to service level agreements, volume discounts entailing variability in revenue earned, and contracts under the Company’s payment integrity services whereby the transaction price is based on the estimated amount the Company enables its customers to recover.
The Company considers its historical experience, including trends with similar transactions and expectations regarding the contract in estimating the amount of variable consideration that should be recognized during a period.
The Company believes that the expected value method is most appropriate for determining the variable consideration since the Company has a large number of contracts with a similar nature of transactions/services.
Unbilled Receivables
Unbilled receivables represents revenues recognized for services rendered between the last billing date and the balance sheet date.
Deferred Revenue and Contract Fulfillment Costs
Contract liabilities (deferred revenue) consist of advance billings and billing in excess of revenues recognized. Deferred revenue also includes the amount for which services have been rendered but other conditions of revenue recognition are not met, for example, where the Company does not have an enforceable contract.
Further, the Company also defers any upfront payments collected from its customers attributable to certain process transition activities, with respect to its customers where such activities do not represent separate performance obligations. Revenues related to such transition activities are classified under “Deferred revenue” and “Other non-current liabilities” in the Company’s consolidated balance sheets and are recognized as (or when) the performance obligation is fulfilled under the contract with customer.
Costs related to such transition activities are contract fulfillment costs, and thereby classified under “Other current assets” and “Other assets” in the consolidated balance sheets, and are recognized over the expected duration of the relationship with customers, under “Cost of revenues” in the consolidated statements of income.
Contract Acquisition Costs
Incremental costs incurred for acquiring contracts, such as sales commissions are contract acquisition costs and thereby classified under “Other current assets” and “Other assets” in the consolidated balance sheets. Such costs are amortized over the expected duration of the relationship with customers and recorded under Selling and marketing expenses in the consolidated statements of income.
Upfront Payments Made to Customers
Upfront payments, in nature of deal signing discount or deal signing bonuses made to customers are contract assets and classified under “Other current assets and Other assets” in the consolidated balance sheets. Such costs are amortized over the expected period of benefit and are recorded as an adjustment to transaction price and reduced from revenues.
Out-of-Pocket Expenses
Reimbursements of out-of-pocket expenses received from customers are included as part of revenues.
Payment terms
All contracts entered into by the Company specify the payment terms and are defined for each contract separately. Usual payment terms range between 30-60 days. The Company does not have any extended payment terms clauses in existing contracts.
Remaining Performance Obligations
The Company does not disclose the value of remaining performance obligations as a result of applying the practical expedient provided in ASC Topic 606, for contracts that meet any of the following criteria:
i. Contracts with an original expected length of one year or less as determined under ASC Topic 606,
ii. Contracts for which Company recognize revenue based on the right to invoice for service performed.
(e)Cash and Cash Equivalents and Restricted Cash
The Company considers all highly liquid investments purchased with an original maturity of ninety days or less to be cash equivalents. Pursuant to the Company’s investment policy, surplus funds are invested in highly-rated debt mutual funds, money market funds and time deposits to reduce its exposure to market risk with regard to these funds.
The Company’s investment in money market funds is considered as cash equivalents. These investments are accounted for in accordance with the fair value option under ASC Topic 825, Financial Instruments. The fair value is represented by original cost on the acquisition date and the net asset value (“NAV”) as quoted, at each reporting period and any changes in fair value are included in other income/(expense), net. Gain or loss on the disposal of these investments is calculated using the first in, first out (“FIFO”) method and is included in other income/(expense), net.
Restricted cash includes any cash and cash equivalents that are legally restricted as to withdrawal or usage for the Company’s operations.
For purposes of the statements of cash flows, the Company includes in its cash and cash-equivalent balances those amounts that have been classified as restricted cash and restricted cash equivalents.
(f)Short-Term and Long-Term Investments
The Company’s short-term investments consist of investments in mutual funds and those term deposits with more than three months of original maturity and less than twelve months of remaining maturity as of the reporting date, while long-term investments consist of term deposits with more than twelve months of remaining maturity as of the reporting date and investments in equity affiliate.
The Company’s investments in term deposits with financial institutions are measured and recognized at amortized cost. Interest earned on such investments is included in other income/(expense), net.
The Company’s mutual fund investments are in debt funds invested in India. These investments are accounted for in accordance with the fair value option under ASC Topic 825, Financial Instruments. The fair value is represented by original cost on the acquisition date and the net asset value (“NAV”) as quoted, at each reporting period and any changes in fair value are included in other income/(expense), net. Gain or loss on the disposal of these investments is calculated using the FIFO method and is included in other income/(expense), net.
Investments in equity affiliates are initially recorded at cost and any excess purchase consideration paid over proportionate share of the fair value of the net assets of the investee at the acquisition date is recognized as goodwill. The proportionate share of net income or loss of the investee after its acquisition is recognized in the consolidated statements of income. The Company periodically reviews the carrying value of its investment to determine if there has been any other than temporary decline in carrying value. The investment balance for an investee is increased or decreased for cash contribution and distributions to or from, respectively.
(g)Accounts Receivable and Allowance for Expected Credit Losses
Accounts receivable are recorded net of allowances for expected credit losses. The Company evaluates the credit risk of its customers based on a combination of various financial and qualitative factors that may affect the ability of each customer to pay. The Company considered current and anticipated future economic conditions relating to the industries of the Company’s customers and the countries where it operates. In calculating expected credit loss, the Company also considered past payment trends, credit rating and other related credit information for its significant customers to estimate the probability of default in the future. Accounts receivable balances are written-off against the allowance for expected credit losses after all means of collection have been exhausted and the potential for recovery is considered remote.
Accounts receivable include unbilled accounts receivable which represent revenues on contracts to be billed, in subsequent periods, as per the terms of the related contracts.
(h)Property and Equipment
Property and equipment are stated at cost, which is generally comprised of the purchase price for such property or equipment, non-refundable duties and taxes, but excludes any discounts and/or rebates, less accumulated depreciation and impairment. Equipment held under finance leases are capitalized at the commencement of the lease at an amount equal to the lease liability, adjusted for any lease prepayments, initial direct costs and lease incentives, which usually approximate the fair value of the underlying asset. Expenditures for replacements and improvements are capitalized, if they enhance the production capacity and future benefits whereas the costs of maintenance and repairs are charged to earnings as incurred. Advances paid towards acquisition of property and equipment and the cost of property and equipment not yet placed in service before the end of the reporting period, net of impairment, if any, are classified as capital work in progress.
Depreciation is computed using the straight-line method over the estimated useful lives of the assets and is presented under “Depreciation and amortization expense” in the consolidated statements of income.
The Company reviews property and equipment for impairment whenever events or changes in circumstances indicate that the related carrying amounts may not be recoverable. The estimated useful life have been disclosed in Note 9 - Property and Equipment to the consolidated financial statements.
(i)Software Development Costs
The Company capitalizes certain costs related to the development or enhancements to existing software products to be sold, leased or otherwise marketed and / or used for internal-use. The Company begins to capitalize costs to develop or enhance software when planning stage efforts are successfully completed, management has authorized and committed project funding, and it is probable that the project will be completed and the software will be used as intended. Costs incurred prior to meeting these criteria, together with costs incurred for training and maintenance, are expensed as incurred and recorded within “General and administrative expenses” in the Company’s consolidated statements of income. Costs incurred on internally developed software not yet ready for its intended use before the end of the reporting period, net of impairment, if any, are classified as capital work in progress. The Company exercises judgment in determining the point at which various projects may be capitalized, in assessing the ongoing value of the capitalized costs, and in determining the estimated useful lives over which the costs are amortized.
Annual amortization of internally developed software products meant for sale, lease or otherwise marketing is the greater of the amount computed using the ratio that current gross revenues for a product bear to the total of current and anticipated future gross revenues for that product or the straight-line method over the remaining estimated economic life of the software product, generally estimated to be up to 5 years from the date the product became available for use. Annual amortization of internally developed software products meant for internal-use is based on the straight-line method over the estimated useful lives of the internally developed software products. Amortization of such internally developed software is presented under “Depreciation and amortization expense” in the consolidated statements of income.
(j)Business Combinations, Goodwill and Other Intangible Assets
ASC Topic 805, Business Combinations, requires that the acquisition method of accounting be used for all business combinations. The guidance specifies criteria as to intangible assets acquired in a business combination that must be recognized and reported separately from goodwill. Contingent consideration is recognized at its fair value on the acquisition date. A liability resulting from contingent consideration is re-measured to fair value as of each reporting date until the contingency is resolved, whereby such changes in fair value are recognized in earnings. Under ASC Topic 350, Intangibles - Goodwill and Other, all assets and liabilities of the acquired businesses, including goodwill, are assigned to reporting units. Acquisition related costs are expensed as incurred under general and administrative expenses.
In addition, assets acquired and liabilities assumed including uncertain tax positions and tax-related valuation allowances in connection with business combinations are initially estimated as of the acquisition date. The Company subsequently re-evaluates the assets acquired and liabilities assumed, including additional assets and liabilities identified subsequent to acquisition date, with any adjustments to its preliminary estimates being recorded to goodwill within the measurement period (up to one year from the acquisition date).
Goodwill represents the cost of the acquired businesses in excess of the fair value of identifiable tangible and intangible net assets purchased in a business combination. The Company undertakes studies to determine the fair values of assets and liabilities acquired and allocates purchase consideration to assets and liabilities, including property and equipment, goodwill and other identifiable intangibles. Goodwill is not amortized but is tested for impairment at least on an annual basis, relying on a number of factors including operating results, business plans and estimated future cash flows of the reporting units to which it is assigned. The Company examines the carrying value and fair value of the reporting unit that includes goodwill as and when the circumstances warrant, to determine whether there are any impairment losses. Refer to Note 10 - Business Combinations, Goodwill and Other Intangible Assets to the consolidated financial statements.
The Company performs an assessment of qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. Based on the assessment of events or circumstances, the Company performs a quantitative assessment of goodwill impairment if it determines that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If, based on the quantitative impairment analysis, the carrying value of the goodwill of a reporting unit exceeds the fair value of such goodwill, an impairment loss is recognized in an amount equal to the excess, limited to the total amount of goodwill allocated to that reporting unit. In addition, the Company performs a qualitative assessment of goodwill impairment between annual tests if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying amount.
Intangible assets acquired in a business combination are initially valued and recognized at fair market value using generally accepted valuation methods appropriate for the type of intangible asset. Intangible assets with definite lives are amortized over the estimated useful lives and are reviewed for impairment, if indicators of impairment arise. Amortization of intangible assets with definite lives is presented under “Depreciation and amortization expense” in the consolidated statements of income. The evaluation of impairment is based upon a comparison of the carrying amount of the intangible asset to its fair value, which is calculated using the estimated future undiscounted net cash flows expected to be generated by the asset. If the fair value of the intangible assets is less than the carrying amount of the asset, the asset is considered impaired and an impairment expense is recognized equal to any shortfall in the current period.
The Company’s definite lived intangible assets are amortized over their estimated useful lives as listed below using a straight-line method:
| Useful Lives(in years) | |
|---|---|
| Customer relationships | 5-15 |
| Developed technology | 3-10 |
| Non-compete agreements | 3-5 |
| Trade names and trademarks | 2-10 |
(k)Impairment of Long-lived Assets
Long-lived assets to be held and used are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. Such assets are required to be tested for impairment if the carrying amount of the assets is higher than the future undiscounted net cash flows expected to be generated from the assets. Determining whether an impairment has occurred typically requires various estimates and assumptions, including determining which undiscounted cash flows are directly related to the potentially impaired asset, the useful life over which cash flows will occur, their amount, and the asset’s residual value, if any. In turn, measurement of an impairment loss requires a determination of fair value, which is based on the best information available. The Company derives the required undiscounted cash flow estimates from its historical experience and its internal business plans. To determine fair value, the Company follows the discounted cash flow approach and uses its internal cash flow estimates discounted at an appropriate discount rate and independent appraisals, as appropriate. The impairment amount to be recognized is measured as the amount by which the carrying value of the assets exceeds their fair value.
(l) Derivative Financial Instruments
In the normal course of business, the Company uses derivative instruments to mitigate the exposure from risk of foreign currency and interest rate fluctuations. The Company enters into foreign currency forward contracts to hedge cash flow risks from forecasted transactions denominated in certain foreign currencies, and interest rate swaps to hedge cash flow risks from its revolving credit facility having variable interest rate obligations. These contracts adhere to the Company’s treasury operations’ objectives and policies to qualify as cash flow hedges, and are with counterparties that are highly rated financial institutions.
Changes in the fair value of these cash flow hedges are recorded as a component of accumulated other comprehensive income/(loss) (“AOCI”), net of tax. The resultant foreign exchange gain/(loss) upon settlement of cash flow hedges of forecasted transactions are recorded in the consolidated statements of income along with the underlying hedged item in the same line as part of “Cost of revenues,” “General and administrative expenses,” “Selling and marketing expenses,” and “Depreciation and amortization expense,” as applicable. The accumulated changes in the fair value of interest rate swaps recognized in AOCI are reclassified to the consolidated statements of income and are presented as a part of “Interest expense” over the term of the contract.
The Company evaluates hedge effectiveness of cash flow hedges at the time a contract is entered into as well as on an ongoing basis. For hedge relationships that are discontinued because the forecasted transaction is not expected to occur by the end of the originally specified period, any related derivative amounts recorded in AOCI are reclassified to earnings.
The Company also uses derivatives instruments consisting of foreign currency forward contracts to hedge intercompany balances and other monetary assets or liabilities denominated in currencies other than the functional currency, against the risk of foreign currency fluctuations associated with remeasurement of such assets and liabilities to functional currency. These derivatives do not qualify as fair value hedges under ASC Topic 815. Changes in the fair value of these derivatives are recognized in the consolidated statements of income and are included in foreign exchange gain, net.
The Company also uses foreign currency forward contracts designated as net investment hedges to hedge the foreign currency risks related to the Company's investment in foreign subsidiaries. Fair value changes on these forward contracts and gains and losses on settlement of such forward contracts are recognized in AOCI as part of the foreign currency translation adjustments and are reclassified to consolidated statements of income when a foreign operation is disposed or partially disposed.
All of the assets and liabilities related to the Company’s forward contracts are subject to master netting arrangements with each individual counterparty. These master netting arrangements generally provide for net settlement of all outstanding contracts with the counterparty in the case of an event of default or a termination event. The Company has presented all of the assets and liabilities related to these contracts on a gross basis, with no offsets, in its consolidated statements of financial position. There is no financial collateral (including cash collateral) provided or received by the Company related to these contracts.
(m)Employee Benefits
Contributions to defined contribution plans are charged to the consolidated statements of income in the period in which services are rendered by the covered employees. Current service costs for defined benefit plans are recognized in the period to which they relate. The liability in respect of defined benefit plans is calculated annually by the Company using the projected unit credit method.
The Company records annual amounts relating to its defined benefit plans based on calculations that incorporate various actuarial and other assumptions, including discount rates, mortality, assumed rates of return on plan assets, future compensation increases and attrition rates. The Company reviews its assumptions on an annual basis and makes modifications to the assumptions based on current rates and trends when it is appropriate to do so. The effect of modifications to those assumptions is recorded in other comprehensive income (loss) (“OCI”) and amortized to net periodic benefit cost over the expected remaining period of service of the covered employees using the corridor method. The Company believes that the assumptions utilized in recording its obligations under its plans are reasonable based on its experience and market conditions. These assumptions may not be within the control of the Company and accordingly it is reasonably possible that these assumptions could change in future periods.
The Company includes the service cost component of the net periodic benefit cost in the same line item or items as other compensation costs arising from services rendered by the respective employees during the period. The interest cost, expected return on plan assets and amortization of actuarial gains/loss, are included in “Other income/(expense), net.” Refer to Note 20 - Employee Benefit Plans to the consolidated financial statements.
The Company recognizes its liabilities for compensated absences depending on whether the obligation is attributable to employee services already rendered, rights to compensated absences vest or accumulate and payment is probable and estimable.
(n)Stock-Based Compensation
The Company recognizes stock-based compensation expense in the consolidated statements of income for awards of equity instruments to employees and non-employee directors based on the grant-date fair value of those awards. The Company recognizes these compensation costs on straight-line basis over the requisite service period of the award, or to the date on which retirement eligibility is achieved, if shorter. Forfeitures are accounted when the actual forfeitures occur.
Under the Company’s 2018 Omnibus Incentive Plan (the “2018 Plan”), which was adopted by the Company's stockholders on June 15, 2018, which replaces and supersedes the 2015 Amendment and Restatement of the Company’s 2006 Omnibus Award Plan (the “Prior Plan”) and is effective upon the date approved by the Company’s stockholders, the Company grants performance-based restricted stock units (“PRSU”) to executive officers and other specified employees. Generally, the Company grants PRSUs that cliff vest based on an aggregated revenue target (“PU”) for athree-year period, and PRSUs that are based on market conditions (“MU”) and cliff vest upon meeting or exceeding the Company's total shareholder return relative to a group of peer companies specified under the 2018 Plan, and are measured over athree-year performance period. The award recipient may earn up to 200% of the PRSUs granted based on the actual achievement of the respective targets. However, the features of the equity incentive compensation program are subject to change by the Compensation and Talent Management Committee of the Company’s board of directors.
The fair value of each PU is determined based on the market price of one common share of the Company on the day prior to the date of grant, and the associated compensation expense is calculated on the basis that performance targets at 100% are probable of being achieved. The compensation expense for the PU is recognized on a straight-line basis over the service period, which is through the end of the third year. Over this period, the number of shares that will be issued is adjusted upward or downward based upon the probability of achievement of the performance targets. The final number of shares issued and the related compensation cost recognized as an expense will be based on a comparison of the final performance metrics to the specified targets. The expense related to the unvested PU as of December 31, 2024 was based on the Company's assessment of performance criteria for these grants that would most likely be met during the respective years of vesting against the targeted performance level.
The grant date fair value for the MUs is determined using a Monte Carlo simulation model and the related compensation expense is expensed on a straight-line basis over the vesting period. All compensation expense related to the MU will be recognized if the requisite performance period is fulfilled, regardless of the extent of the market condition achieved.
Stock-based compensation expense associated with the Company's 2022 Employee Stock Purchase Plan (“ESPP”) is measured at fair-value using a Black-Scholes option-pricing model at the commencement of each offering period and recognized over that offering period.
(o)Income Taxes
The Company accounts for income taxes using the asset and liability method of accounting for income taxes. The Company calculates and provides for income taxes in each of the tax jurisdictions in which it operates. The deferred tax assets and liabilities are recognized for future tax consequences attributable to temporary differences between the financial statement carrying values of existing assets and liabilities and their respective tax bases and all operating losses carried forward, if any. Deferred tax assets and liabilities are measured using tax rates expected to apply to taxable income in the years in which the applicable temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates or tax status is recognized in the statements of income in the period in which the change is identified. The Company releases (reclassifies) the tax effects from AOCI to the consolidated statements of income at the time of settlement of cash flows hedges and amortization of deferred actuarial gain/(loss) on retirement benefits. Deferred tax assets are reduced by a valuation allowance if, based on available evidence, it is more likely than not that some portion or all of the deferred tax assets will not be realized.
The Company establishes provisions for uncertain tax provisions and related interest and penalties when the Company believes those tax positions are not more likely than not of being sustained, if challenged.
The Company has indefinitely reinvested earnings from its foreign subsidiaries through December 31, 2023, and has not recorded deferred tax liabilities for such earnings. Beginning 2024, the Company is not indefinitely investing current year earnings of the Company’s foreign disregarded subsidiaries and is not recording any deferred tax liabilities. However, the Company continues to indefinitely reinvest earnings from its controlled foreign corporation subsidiaries and has not recorded deferred tax liabilities for such earnings.
The Company recognizes the tax effects of Global Intangible Low-Taxed Income of certain foreign subsidiaries as a period cost.
(p)Concentration of Credit Risk in Financial Instruments
Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, time deposits, mutual fund investments, accounts receivable and derivative financial instruments. By their nature, all such financial instruments involve risks including the credit risks of non-performance by counterparties. Pursuant to the Company’s investment policy, surplus funds are maintained as cash equivalents and short-term investments, and are invested in highly-rated mutual funds, money market funds and time deposits, placed with highly rated financial institutions to reduce its exposure to market risk with regard to these funds. The Company’s exposure to credit risk on account receivable is influenced mainly by the individual characteristic of each customer and the concentration of risk from the top few customers. To mitigate this risk the Company evaluates the creditworthiness of its customers in conjunction with its revenue recognition processes as well as through its ongoing collectability assessment processes for accounts receivable. The Company does not enter into or trade financial instruments, including derivative financial instruments, for speculative purposes.
(q)Fair value measurements
ASC Topic 820, Fair Value Measurements and Disclosures defines fair value as the price that would be received upon sale of an asset or paid upon transfer of a liability in an orderly transaction between market participants at the measurement date and in the principal or most advantageous market for that asset or liability. The fair value should be calculated based on assumptions that market participants would use in pricing the asset or liability as against assumptions specific to the entity. In addition, the fair value of liabilities should include consideration of non-performance risk, including the Company’s own credit risk. The fair value hierarchy consists of the following three levels:
Level I — Quoted prices for identical instruments in active markets.
Level II — Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable.
Level III — Instruments whose significant value drivers are unobservable.
(r)Leases
The Company determines if an arrangement is a lease at inception of the contract. The Company’s assessment is based on whether: (1) the contract involves the use of a distinct identified asset, (2) the Company obtains the right to substantially all the economic benefit from the use of the asset throughout the term of the contract, and (3) the Company has the right to direct the use of the asset. A lease is classified as a finance lease if any one of the following criteria are met: (1) the lease transfers ownership of the asset by the end of the lease term, (2) the lease contains an option to purchase the asset that is reasonably certain to be exercised, (3) the lease term is for a major part of the remaining useful life of the asset or (4) the present value of the lease payments equals or exceeds substantially all of the fair value of the asset.
Operating leases are presented within “Operating lease right-of-use assets,” “Current portion of operating lease liabilities” and “Operating lease liabilities, less current portion” in the Company's consolidated balance sheets. Long-lived assets underlying finance leases are presented within “Property and equipment” and the current and non-current portion of finance lease liabilities are presented within “Accrued expenses and other current liabilities - others” and “other non-current liabilities - others,” respectively, in the Company's consolidated balance sheets.
ROU assets represent the Company’s right to use an underlying asset during the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease arrangement. Lease liabilities are recognized at commencement date based on the present value of lease payments over the lease term. Operating lease ROU assets are recognized at commencement date in an amount equal to lease liability, adjusted for any lease prepayments, initial direct costs, and lease incentives. For leases in which the rate implicit in the lease is not readily determinable, the Company uses its incremental borrowing rate based on the information available at commencement date. The Company determines the incremental borrowing rate by adjusting the benchmark reference rates with appropriate financing spreads applicable to the respective geographies where the leases are entered and lease specific adjustments for the effects of collateral, if applicable. Lease terms includes the effects of options to extend or terminate the lease when it is reasonably certain at commencement of the lease that the Company will exercise that option. Lease expense for operating lease arrangements is recognized on a straight-line basis over the lease term reflecting single operating lease cost. The Company evaluates lease agreements to determine lease and non-lease components, which are accounted for separately.
Lease payments that depend on factors other than an index or rate are considered variable lease payments and are excluded from the operating lease assets and liabilities and are recognized as expense in the period in which the obligation is incurred. Lease payments include payments for common area maintenance, utilities such as electricity, heating and water, among others, and property taxes, and other similar payments paid to the landlord, which are treated as non-lease component.
The Company accounts for lease-related concessions in accordance with guidance in Topic 842, Leases, to determine, on a lease-by-lease basis, whether the concession provided by lessor should be accounted for as a lease modification.
The Company accounts for a modification as a separate contract when it grants an additional right of use not included in the original lease and the increase is commensurate with the standalone price for the additional right of use, adjusted for the circumstances of the particular contract. Modifications which are not accounted for as a separate contract are reassessed as of the effective date of the modification based on its modified terms and conditions and the facts and circumstances as of that date. Upon modification, the Company remeasures the lease liability to reflect changes to the remaining lease payments and discount rates and recognizes the amount of the remeasurement of the lease liability as an adjustment to the ROU assets. However, if the carrying amount of the ROU assets is reduced to zero as a result of modification, any remaining amount of the remeasurement is recognized as an expense in consolidated statements of income.
The Company reviews ROU assets for impairment whenever events or changes in circumstances indicate that the related carrying amount may not be recoverable.
(s)Earnings per share
Basic earnings per share is computed by dividing net income attributable to common stockholders by the weighted average number of common shares outstanding, adjusted for outstanding shares that are subject to repurchase during the period. Diluted earnings per share is computed using the weighted average number of common shares issued and outstanding during the period plus the potentially dilutive effect of common stock equivalents, including, outstanding stock options, restricted stock, restricted stock units and employee stock purchase plans. For the purposes of calculating diluted earnings per share, the treasury stock method is used for stock-based awards. The Company includes performance stock unit awards in dilutive potential common shares when they become contingently issuable and have a dilutive impact per authoritative guidance and excludes such awards when they are not contingently issuable.
(t)Commitments and Contingencies
Liabilities for loss contingencies arising from claims, assessments, litigation, fines and penalties, and other sources are recognized when it is probable that a liability has been incurred and the amount of the assessment and/or remediation can be reasonably estimated. A disclosure for a contingent liability is made when there is a possible obligation that may require an outflow of resources. When there is a possible obligation or a present obligation in respect of which the likelihood of outflow of resources is remote, no provision or disclosure is made. Legal costs incurred in connection with such liabilities are expensed as incurred. Capital commitments are disclosed in the financial statements.
(u)Recent Accounting Pronouncements
In October 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) 2023-06, Disclosure Improvements: Codification Amendments in Response to the SEC’s Disclosure Update and Simplification Initiative. This ASU modifies the disclosure or presentation requirements of a variety of Topics in the Codification. Certain of the amendments represent clarifications to or technical corrections of the current requirements. For entities subject to the SEC’s existing disclosure requirements and for entities required to file or furnish financial statements with or to the SEC in preparation for the sale of or for purposes of issuing securities that are not subject to contractual restrictions on transfer, the effective date for each amendment will be the date on which the SEC’s removal of that related disclosure from Regulation S-X or Regulation S-K becomes effective, with early adoption prohibited. The amendments in this ASU should be applied prospectively. For all entities, if by June 30, 2027, the SEC has not removed the applicable requirement from Regulation S-X or Regulation S-K, the pending content of the related amendment will be removed from the Codification and will not become effective for any entity.
The adoption of this ASU will not have a material impact on the Company’s consolidated financial statements. The Company will continue to monitor for SEC action, and plan accordingly for adoption.
In December 2023, FASB issued ASU No. 2023-09, Income Taxes (“Accounting Standards Codification (“ASC”) Topic 740”), Improvements to Income Tax Disclosures. This ASU expands disclosures relating to the entity’s income tax rate reconciliation, income taxes paid and certain other disclosures related to income taxes. The ASU will be effective for annual periods beginning after December 15, 2024. The Company is currently evaluating the impact of this ASU on its consolidated financial statements.
In November 2024, FASB issued ASU No. 2024-03, Income Statement - Reporting Comprehensive Income (“ASC Topic 220”): Expense Disaggregation Disclosures. This ASU improves disclosures relating to the disaggregation of income statement expenses, requires additional disclosures about the nature of expenses in commonly presented financial statement captions on an annual and interim basis for all public business entities. The ASU will be effective for annual periods beginning after December 15, 2026, with early adoption permitted. The Company is currently evaluating the impact of this ASU on its consolidated financial statements.
(v) Recently Adopted and Applicable Accounting Pronouncements
In November 2023, FASB issued ASU No. 2023-07, Segment Reporting (“ASC Topic 280”): Improvements to Reportable Segment Disclosures. This ASU improves reportable segment disclosure requirements for all public entities by requiring disclosure of significant segment expenses that are regularly reviewed by the chief operating decision maker (“CODM”) and included within each reported measure of segment profit or loss and other segment items. The ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company has adopted this ASU, the impact of which is reflected in Note 3 - Segment and Geographical Information to the consolidated financial statements.
In March 2024, FASB issued ASU No. 2024-01, Compensation-Stock Compensation (“ASC Topic 718”). This ASU clarifies how to evaluate whether profits interest and similar awards given to employees and non-employees are within the scope of share-based payment arrangement under ASC Topic 718. The ASU will be effective for annual periods beginning after December 15, 2024, including interim periods within those years, with early adoption permitted. The Company has early adopted this ASU beginning January 1, 2024. The adoption of this ASU did not have a material impact on the Company’s consolidated financial statements.
In March 2024, FASB issued ASU No. 2024-02, Codification Improvements—Amendments to Remove References to the Concepts Statements. This ASU contains amendments to the ASC that remove references to various FASB Concepts Statements. The ASU will be effective for annual periods beginning after December 15, 2024, with early adoption permitted. The Company has early adopted this ASU beginning January 1, 2024. The adoption of this ASU did not have a material impact on the Company’s consolidated financial statements.
- Segment and Geographical Information
The Company is a provider of data analytics and digital operations and solutions.
The Company manages and reports financial information through itsfour reportable segments: Insurance, Healthcare, Analytics and Emerging Business, which reflects how management reviews financial information and makes operating decisions. These business units develop client-specific solutions, build capabilities, maintain a unified go-to-market approach and are integrally responsible for service delivery, customer satisfaction, growth and profitability.
The Company’s Chief Executive Officer has been identified as the Chief Operating Decision Maker ("CODM"). The CODM generally reviews financial information such as revenues, cost of revenues and gross profit to allocate an overall budget and measure segment performance.
The CODM uses revenue, cost of revenues and gross profit for each segment predominantly in the annual budgeting and forecasting process. The CODM considers budget-to-actual variances on a quarterly basis for making decisions about the allocation of operating and capital resources to each segment. The CODM also uses segment gross profit for evaluating pricing strategy and performance of each individual segment.
The August 2024 acquisition of Incandescent Technologies, Inc. (“ITI Data”) is included in the Analytics reportable segment. Refer to Note 10 - Business Combinations, Goodwill and Other Intangible Assets to the consolidated financial statements for further details.
Revenues and cost of revenues for the years ended December 31, 2024, 2023 and 2022, respectively, for each of the reportable segments, are as follows:
| Year ended December 31, 2024 | ||||||
|---|---|---|---|---|---|---|
| Insurance · Healthcare · Emerging Business · Analytics · Total | ||||||
| Revenues, net | $614,028 | $116,406 | $311,740 | $796,198 | $1,838,372 | |
| Cost of revenues (1) | ||||||
| Employee costs (2) | 320,335 | 63,597 | 147,316 | 416,293 | 947,541 | |
| Infrastructure and technology costs | 58,415 | 11,049 | 29,813 | 27,582 | 126,859 | |
| Other costs (3) | 11,600 | 3,288 | 4,278 | 53,793 | 72,959 | |
| Gross profit (1) | $223,678 | $38,472 | $130,333 | $298,530 | $691,013 | |
| Operating expenses | 427,393 | |||||
| Foreign exchange gain, net, interest expense and other income, net | (2,273) | |||||
| Income tax expense | 62,936 | |||||
| Loss from equity-method investment | (114) | |||||
| Net income | $198,297 | |||||
(2) Employee costs include restructuring costs of $607, $16, $73 and $2,382 for Insurance, Healthcare, Emerging Business and Analytics segments respectively. Refer to Note 26 – Restructuring Costs to the consolidated financial statements for further details.
(3) Other costs primarily include travel and entertainment costs and direct expenses related to lead generation and direct marketing business which are a part of analytics business segment.
| Year ended December 31, 2023 | ||||||
|---|---|---|---|---|---|---|
| Insurance · Healthcare · Emerging Business · Analytics · Total | ||||||
| Revenues, net | $529,855 | $105,994 | $265,692 | $729,127 | $1,630,668 | |
| Cost of revenues (1) | ||||||
| Employee costs | 281,108 | 56,026 | 121,278 | 382,550 | 840,962 | |
| Infrastructure and technology costs | 49,633 | 9,872 | 25,922 | 20,046 | 105,473 | |
| Other costs (2) | 11,044 | 3,375 | 3,743 | 58,305 | 76,467 | |
| Gross profit (1) | $188,070 | $36,721 | $114,749 | $268,226 | $607,766 | |
| Operating expenses | 369,011 | |||||
| Foreign exchange gain, net, interest expense and other income, net | (814) | |||||
| Income tax expense | 53,536 | |||||
| Gain from equity-method investment | 153 | |||||
| Net income | $184,558 | |||||
(2) Other costs primarily include travel and entertainment costs and direct expenses related to lead generation and direct marketing business which are a part of analytics business segment.
| Year ended December 31, 2022 | ||||||
|---|---|---|---|---|---|---|
| Insurance · Healthcare · Emerging Business · Analytics · Total | ||||||
| Revenues, net | $448,704 | $97,351 | $218,638 | $647,351 | $1,412,044 | |
| Cost of revenues (1) | ||||||
| Employee costs | 236,963 | 55,532 | 101,978 | 333,876 | 728,349 | |
| Infrastructure and technology costs | 41,126 | 11,889 | 22,556 | 19,340 | 94,911 | |
| Other costs (2) | 9,645 | 3,530 | 3,483 | 56,677 | 73,335 | |
| Gross profit (1) | $160,970 | $26,400 | $90,621 | $237,458 | $515,449 | |
| Operating expenses | 323,287 | |||||
| Foreign exchange gain, net, interest expense and other expense, net | (2,063) | |||||
| Income tax expense | 47,565 | |||||
| Gain from equity-method investment | 434 | |||||
| Net income | $142,968 | |||||
(2) Other costs primarily include travel and entertainment costs and direct expenses related to lead generation and direct marketing business which are a part of analytics business segment.
Revenues, net by service type, were as follows:
| Year ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Digital operations and solutions (1) | $1,042,174 | $901,541 | $764,693 |
| Analytics services | 796,198 | 729,127 | 647,351 |
| Revenues, net | $1,838,372 | $1,630,668 | $1,412,044 |
(1) Digital operations and solutions include revenues of the Company’s Insurance, Healthcare and Emerging Business reportable segments. Refer to the reportable segment disclosure above.
The Company attributes the revenues to regions based upon the location of its customers.
| Year ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Revenues, net | |||
| The United States | $1,518,894 | $1,370,707 | $1,213,477 |
| Non-United States | |||
| The United Kingdom | 215,958 | 177,479 | 134,630 |
| Rest of World | 103,520 | 82,482 | 63,937 |
| Total Non-United States | 319,478 | 259,961 | 198,567 |
| Revenues, net | $1,838,372 | $1,630,668 | $1,412,044 |
Long-lived assets by geographic area, which consist of property and equipment, net and operating lease ROU assets were as follows:
| As of | ||
|---|---|---|
| December 31, 2024 | December 31, 2023 | |
| Long-lived assets | ||
| India | $63,040 | $53,813 |
| The United States | 52,510 | 61,592 |
| The Philippines | 25,881 | 21,952 |
| South Africa | 23,828 | 20,890 |
| Rest of World | 5,362 | 6,982 |
| Long-lived assets | $170,621 | $165,229 |
- Revenues, net and Accounts Receivable, net
Refer to Note 3 - Segment and Geographical Information to the consolidated financial statements for revenues disaggregated by reportable segments and geography.
Contract balances
The following table provides information about accounts receivable, contract assets and contract liabilities from contracts with customers:
| As of | ||
|---|---|---|
| December 31, 2024 | December 31, 2023 | |
| Accounts receivable, net | $304,322 | $308,108 |
| Contract assets | $39,700 | $9,665 |
| Contract liabilities: | ||
| Deferred revenue (consideration received in advance) | $15,484 | $9,764 |
| Consideration received for process transition activities | $21,993 | $12,411 |
Accounts receivable includes $121,817 and $148,735 as of December 31, 2024 and 2023, respectively, representing unbilled receivables. The Company has accrued the unbilled receivables for work performed in accordance with the terms of contracts with customers and considers no performance risk associated with its unbilled receivables. Contract assets as of December 31, 2024, includes receivables of $33,472 from our payment integrity services. There are no performance risks associated with these contract assets.
There wereno significant cumulative catch-up impact or impairment related to contract assets as of December 31, 2024 and 2023.
Revenue recognized during the years ended December 31, 2024 and 2023, which was included in the contract liabilities balance at the beginning of the respective periods:
| Year ended December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Deferred revenue (consideration received in advance) | $9,321 | $16,967 |
| Consideration received for process transition activities | $2,657 | $1,762 |
Contract acquisition and fulfillment costs
The following table provides details of the Company’s contract acquisition and fulfillment costs:
| Contract Acquisition Costs · Contract Fulfillment Costs | ||||
|---|---|---|---|---|
| Year ended December 31, | Year ended December 31, | |||
| 2024 | 2023 | 2024 | 2023 | |
| Opening Balance | $2,122 | $1,095 | $24,673 | $13,871 |
| Additions | 1,240 | 1,841 | 15,118 | 13,605 |
| Amortization | (1,075) | (814) | (3,769) | (2,803) |
| Closing Balance | $2,287 | $2,122 | $36,022 | $24,673 |
There wasno significant impairment for contract acquisition and contract fulfillment costs as of December 31, 2024 and 2023.
Allowance for expected credit losses
The following table provides information about accounts receivable, net of allowance for expected credit losses:
| As of | ||
|---|---|---|
| December 31, 2024 | December 31, 2023 | |
| Accounts receivable, including unbilled receivables | $307,850 | $311,811 |
| Less: Allowance for expected credit losses | (3,528) | (3,703) |
| Accounts receivable, net | $304,322 | $308,108 |
The movement in “Allowance for expected credit losses” was as follows:
| Year ended December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Opening Balance | $3,703 | $1,332 |
| Additions/(reductions) | (39) | 2,450 |
| Reductions due to write-off of accounts receivable | (135) | (79) |
| Currency translation adjustments | (1) | — |
| Closing Balance | $3,528 | $3,703 |
Customer and credit risk concentration
No single customer accounted for more than 10% of the Company's revenues, net during the years ended December 31, 2024 and 2023. The Company’s management believes that the loss of any of its top ten clients could have a material adverse effect on its financial performance.
To reduce credit risk, the Company conducts ongoing credit evaluations of its customers. No customer accounted for more than 10% of accounts receivable, net, as of December 31, 2024 and 2023.
- Earnings Per Share
The following table sets forth the computation of basic and diluted earnings per share:
| Year ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Numerators: | |||
| Net income | $198,297 | $184,558 | $142,968 |
| Denominators: | |||
| Basic weighted average common shares outstanding | 162,718,840 | 166,341,213 | 166,651,585 |
| Dilutive effect of stock-based awards | 1,602,816 | 1,820,158 | 2,517,705 |
| Diluted weighted average common shares outstanding | 164,321,656 | 168,161,371 | 169,169,290 |
| Earnings per share: | |||
| Basic | $1.22 | $1.11 | $0.86 |
| Diluted | $1.21 | $1.10 | $0.85 |
| Weighted average potentially dilutive shares considered anti-dilutive and not included in computing diluted earnings per share | 2,073,990 | 1,628,932 | 2,830 |
On March 15, 2024, the Company entered into a master confirmation (the “Master Accelerated Share Repurchase Confirmation”) and a supplemental confirmation (together with the Master Accelerated Share Repurchase Confirmation, the “2024 ASR Agreement”), with Citibank, N.A. (“Citibank”). Refer to Note 19 - Capital Structure to the consolidated financial statements for further details. During the year ended December 31, 2024, the Company recorded the initial delivery and final settlement of shares in treasury stock, which resulted in an immediate reduction of its outstanding shares used to calculate the weighted average common shares outstanding for basic and diluted earnings per share.
- Other Income/(Expense), Net
Other income/(expense), net consists of the following:
| Year ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Gain on sale and fair value mark-to-market on investments | $5,662 | $5,013 | $4,907 |
| Interest and dividend income | 9,921 | 8,027 | 5,229 |
| Fair value changes of contingent consideration (1) | 589 | (1,900) | (8,250) |
| Others, net | (80) | (306) | (1,896) |
| Other income/(expense), net | $16,092 | $10,834 | $(10) |
(1) Refer to Note 16 - Fair Value Measurements to the consolidated financial statements for further details.
- Cash, Cash Equivalents and Restricted Cash
For the purposes of statements of cash flows, cash, cash equivalents and restricted cash consist of the following:
| As of | |||
|---|---|---|---|
| December 31, 2024 | December 31, 2023 | December 31, 2022 | |
| Cash and cash equivalents | $153,355 | $136,953 | $118,669 |
| Restricted cash (current) (1) | 9,972 | 4,062 | 4,897 |
| Restricted cash (non-current) (2) | 8,071 | 4,386 | 2,055 |
| Cash, cash equivalents and restricted cash | $171,398 | $145,401 | $125,621 |
(1) Restricted cash (current) primarily represents funds held on behalf of customers in dedicated bank accounts. The corresponding liability against the same is included under “Accrued Expenses and other current liabilities.” Restricted cash also includes funds held as collateral in a dedicated bank account for irrevocable letters of credit issued in favor of third parties for facility leases.
(2) Restricted cash (non-current) represents deposits with banks against bank guarantees issued through banks in favor of relevant statutory authorities for equipment imports, deposits for obtaining indirect tax registrations and for demands against pending income tax and value added tax (“VAT”) assessments. These deposits with banks will mature one year after the balance sheet date.
- Investments
Investments consist of the following:
| As of | ||
|---|---|---|
| December 31, 2024 | December 31, 2023 | |
| Short-term investments | ||
| Mutual funds | $108,251 | $52,650 |
| Term deposits | 78,972 | 101,231 |
| Total Short-term investments | $187,223 | $153,881 |
| Long-term investments | ||
| Term deposits | $9,295 | $239 |
| Investment in equity affiliate | 4,677 | 4,191 |
| Total Long-term investments | $13,972 | $4,430 |
Refer to Note 16 - Fair Value Measurements to the consolidated financial statements for further details.
- Property and Equipment
Property and equipment consists of the following:
| As of | |||
|---|---|---|---|
| Estimated useful lives (Years) | December 31, 2024 | December 31, 2023 | |
| Owned Assets: | |||
| Network equipment and computers | 3-5 | $167,525 | $149,975 |
| Software | 2-5 | 105,874 | 94,279 |
| Leasehold improvements | 3-8 | 45,819 | 41,933 |
| Office furniture and equipment | 3-8 | 23,898 | 21,199 |
| Motor vehicles | 2-5 | 635 | 686 |
| Buildings | 30 | 929 | 956 |
| Land | — | 608 | 625 |
| Capital work in progress | — | 7,504 | 12,276 |
| 352,792 | 321,929 | ||
| Less: Accumulated depreciation and amortization | (252,667) | (222,333) | |
| $100,125 | $99,596 | ||
| ROU assets under finance leases: | |||
| Network equipment and computers | 56 | 58 | |
| Leasehold improvements | 587 | 604 | |
| Office furniture and equipment | 417 | 427 | |
| Motor vehicles | 2,208 | 1,020 | |
| 3,268 | 2,109 | ||
| Less: Accumulated depreciation | (1,556) | (1,332) | |
| $1,712 | $777 | ||
| Property and equipment, net | $101,837 | $100,373 | |
During the years ended December 31, 2024 and 2023, there were no material changes in estimated useful lives of property and equipment during the ordinary course of operations.
The depreciation and amortization expense, excluding amortization of acquisition-related intangibles, recognized in the consolidated statements of income was as follows:
| Year ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Depreciation and amortization expense | $41,589 | $35,812 | $39,173 |
Internally developed software costs included in property and equipment was as follows:
| As of | ||
|---|---|---|
| December 31, 2024 | December 31, 2023 | |
| Cost | $60,447 | $46,625 |
| Less : Accumulated amortization | (38,243) | (25,413) |
| Internally developed software, net | $22,204 | $21,212 |
The amortization expense on internally developed software recognized in the consolidated statements of income was as follows:
| Year ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Amortization expense | $12,849 | $9,282 | $5,958 |
During the years ended December 31, 2024 and 2023, the Company performed an impairment test of its capitalized software for recoverability and determined that the carrying values of certain software were not fully recoverable. The Company recorded impairment charges amounting to $1,187 and $nil for the years ended December 31, 2024 and 2023, respectively under “Depreciation and amortization” expense in the consolidated statements of income.
- Business Combinations, Goodwill and Other Intangible Assets
Incandescent Technologies, Inc.
On August 1, 2024, the Company, through its wholly owned subsidiary Clairvoyant AI, Inc., completed the acquisition of ITI Data, a Nebraska corporation, pursuant to an equity securities purchase agreement dated July 31, 2024 (the "Purchase Agreement"). The Company purchased 100% of the issued and outstanding equity securities in ITI Data. The ITI Data acquisition is treated as a stock acquisition for tax purposes.
ITI Data is a data management solutions firm that works with the global banks, financial services and healthcare companies. It delivers enterprise business solutions for clients processing significant data volumes with complex data management requirements. The acquisition strengthens the Company’s ability to deliver reliable, data-driven insights to its clients and ultimately drive greater value and innovation across their operations.
The Company’s purchase price allocation to net tangible and intangible assets of ITI Data as at August 1, 2024 is as follows:
| Intangible assets | $12,800 |
|---|---|
| Other assets, net | 220 |
| Goodwill | 15,335 |
| Total purchase consideration (1) | $28,355 |
(1) Includes contingent consideration of $2,700 recognized at fair value as of the date of acquisition.
In connection with this acquisition, the Company recorded $12,500 in customer-related intangibles which are being amortized on a straight-line basis (which approximates the economic pattern of benefits) over the estimated weighted average amortization period of 5 years.
The goodwill recognized represents the acquired capabilities, operating synergies and other benefits expected to result from combining the acquired operations with the Company’s existing operations. The goodwill has been assigned to the Company’s Analytics reportable segment based upon the Company’s assessment of nature of services rendered by ITI Data.
The results of operations of the acquired business and the fair value of the acquired assets and assumed liabilities are included in the Company’s consolidated financial statements with effect from the date of the acquisition. The acquisition did not materially impact the Company's financial position, results of operations or cash flows, and therefore, the Company has not provided any supplemental pro forma results.
Goodwill
The following table sets forth details of changes in goodwill by reportable segment of the Company:
| Insurance | Healthcare | Emerging Business | Analytics | Total | |
|---|---|---|---|---|---|
| Balance as of January 1, 2023 | $49,929 | $21,875 | $47,101 | $286,732 | $405,637 |
| Currency translation adjustments | 106 | (3) | (100) | (1) | 2 |
| Balance as of December 31, 2023 | 50,035 | 21,872 | 47,001 | 286,731 | 405,639 |
| Acquisition | — | — | — | 22,035 | 22,035 |
| Measurement period adjustments | — | — | — | (6,700) | (6,700) |
| Currency translation adjustments | (50) | (5) | (531) | (1) | (587) |
| Balance as of December 31, 2024 | $49,985 | $21,867 | $46,470 | $302,065 | $420,387 |
During the year ended December 31, 2024, the Company recognized measurement period adjustments, which led to decrease in goodwill in an amount of $6,700. These adjustments primarily relate to a change in fair value of contingent consideration and customer-related intangible assets and did not have any significant impact on “Depreciation and amortization” expense in the consolidated statements of income for the year ended December 31, 2024.
During 2024 and 2023, the Company performed an assessment to determine whether events or circumstances exist that may lead to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. Based on such assessment, the Company concluded that there wasno impairment on goodwill as of December 31, 2024 and 2023.
Other Intangible Assets
Information regarding the Company’s intangible assets is set forth below:
| As of December 31, 2024 · As of December 31, 2023 | ||||||
|---|---|---|---|---|---|---|
| GrossCarrying Amount | AccumulatedAmortization | Net CarryingAmount | Gross Carrying Amount | Accumulated Amortization | Net CarryingAmount | |
| Finite-lived intangible assets: | ||||||
| Customer relationships | $108,550 | $(60,667) | $47,883 | $99,050 | $(51,085) | $47,965 |
| Developed technology | 3,529 | (3,311) | 218 | 3,552 | (2,522) | 1,030 |
| Trade names and trademarks | 1,700 | (1,442) | 258 | 1,400 | (1,286) | 114 |
| Non-compete agreements | 300 | (228) | 72 | 336 | (181) | 155 |
| 114,079 | (65,648) | 48,431 | 104,338 | (55,074) | 49,264 | |
| Indefinite-lived intangible assets: | ||||||
| Trade names and trademarks | 900 | — | 900 | 900 | — | 900 |
| Total intangible assets | $114,979 | $(65,648) | $49,331 | $105,238 | $(55,074) | $50,164 |
The amortization expense recognized in the consolidated statements of income was as follows:
| Year ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Amortization expense | $13,630 | $14,678 | $17,109 |
During the years ended December 31, 2024 and 2023, the Company performed an impairment test of its intangible assets for recoverability and determined that the carrying values of certain intangible assets were not fully recoverable. The Company recorded impairment charges amounting to $429 and $nil for the years ended December 31, 2024 and 2023, respectively under “Depreciation and amortization” expense in the consolidated statements of income.
| Estimated future amortization expense related to finite-lived intangible assets as of December 31, 2024 was as follows: | |
|---|---|
| 2025 | $13,120 |
| 2026 | 12,783 |
| 2027 | 11,844 |
| 2028 | 9,228 |
| 2029 | 1,456 |
| Total | $48,431 |
- Other Current Assets
Other current assets consist of the following:
| As of | ||
|---|---|---|
| December 31, 2024 | December 31, 2023 | |
| Advance income tax, net | $49,377 | $23,269 |
| Contract assets | 36,072 | 2,830 |
| Prepaid expenses | 21,061 | 18,171 |
| Receivables from statutory authorities | 19,407 | 18,500 |
| Deferred contract fulfillment costs | 4,281 | 3,303 |
| Advances to suppliers | 4,009 | 1,883 |
| Derivative instruments | 1,973 | 4,308 |
| Others | 4,137 | 4,405 |
| Other current assets | $140,317 | $76,669 |
- Other Assets
Other assets consist of the following:
| As of | ||
|---|---|---|
| December 31, 2024 | December 31, 2023 | |
| Deferred contract fulfillment costs | $31,741 | $21,370 |
| Deposits with statutory authorities | 7,312 | 6,960 |
| Lease deposits | 6,495 | 5,159 |
| Contract assets | 3,628 | 6,835 |
| Prepaid expenses | 2,775 | — |
| Derivative instruments | 852 | 3,299 |
| Others | 3,282 | 5,901 |
| Other assets | $56,085 | $49,524 |
- Accrued Expenses and Other Current Liabilities
Accrued expenses and other current liabilities consist of the following:
| As of | ||
|---|---|---|
| December 31, 2024 | December 31, 2023 | |
| Accrued expenses | $63,548 | $58,736 |
| Payable to statutory authorities | 22,935 | 20,591 |
| Client liabilities | 9,711 | 6,909 |
| Derivative instruments | 7,454 | 2,009 |
| Accrued capital expenditures | 2,059 | 4,134 |
| Contingent consideration | 1,280 | 15,000 |
| Income taxes payable, net | 284 | 1,213 |
| Others | 6,326 | 5,521 |
| Accrued expenses and other current liabilities | $113,597 | $114,113 |
- Other Non-Current Liabilities
Other non-current liabilities consist of the following:
| As of | ||
|---|---|---|
| December 31, 2024 | December 31, 2023 | |
| Retirement benefits | $24,795 | $16,666 |
| Deferred transition revenue | 18,213 | 10,195 |
| Derivative instruments | 4,363 | 216 |
| Unrecognized tax benefits | 1,966 | 1,262 |
| Contingent consideration | 1,420 | 589 |
| Others | 2,816 | 2,534 |
| Other non-current liabilities | $53,573 | $31,462 |
- Accumulated Other Comprehensive Income/(Loss)
Accumulated other comprehensive income/(loss) (“AOCI”) consists of actuarial gain/(loss) on retirement benefits and foreign currency translation adjustments. In addition, the Company enters into foreign currency forward contracts and interest rate swaps, which are designated as cash flow hedges and net investment hedges, as applicable, in accordance with ASC Topic 815, Derivatives and Hedging. Cumulative changes in the fair values of cash flow hedges are recognized in AOCI on the Company’s consolidated balance sheets. The fair value changes are reclassified from AOCI to consolidated statements of income upon settlement of foreign currency forward contracts designated as cash flow hedges of a forecast transaction, whereas such changes for interest rate swaps are reclassified over the term of the contract. Fair value changes related to net investment hedges are included in AOCI and are reclassified to consolidated statements of income when a foreign operation is disposed or partially disposed. The following table sets forth the changes in AOCI during the years ended December 31, 2024, 2023 and 2022:
| Accumulated Other Comprehensive Income/(Loss) | ||||
|---|---|---|---|---|
| Currency translation adjustments | Unrealized gain/(loss) on cash flow hedges | Retirement benefits | Total | |
| Balance as of January 1, 2022 | $(95,437) | $8,420 | $(2,457) | $(89,474) |
| Gains / (losses) recognized during the year | (47,734) | (27,333) | 2,574 | (72,493) |
| Reclassification to net income (1) | — | 1,295 | 592 | 1,887 |
| Income tax effects (2) | 10,032 | 6,315 | (410) | 15,937 |
| Accumulated other comprehensive income/(loss) as of December 31, 2022 | $(133,139) | $(11,303) | $299 | $(144,143) |
| Gains recognized during the year | 652 | 14,403 | 1,337 | 16,392 |
| Reclassification to net income (1) | — | 5,208 | (94) | 5,114 |
| Income tax effects (2) | (156) | (4,110) | (137) | (4,403) |
| Accumulated other comprehensive income/(loss) as of December 31, 2023 | $(132,643) | $4,198 | $1,405 | $(127,040) |
| Losses recognized during the year | (17,484) | (14,513) | (1,414) | (33,411) |
| Reclassification to net income (1) | — | (131) | (602) | (733) |
| Income tax effects (2) | 3,129 | 2,898 | 435 | 6,462 |
| Accumulated other comprehensive loss as of December 31, 2024 | $(146,998) | $(7,548) | $(176) | $(154,722) |
(1) Refer to Note 17 - Derivatives and Hedge Accounting and Note 20 - Employee Benefit Plans to the consolidated financial statements for reclassification to net income.
(2) These are income tax effects recognized on cash flow hedges, retirement benefits and currency translation adjustments . Refer to Note 22 - Income Taxes to the consolidated financial statements.
- Fair Value Measurements
Assets and Liabilities Measured at Fair Value
The following table sets forth the Company’s assets and liabilities that were recognized at fair value:
| Quoted Prices in Active Markets for Identical Assets · Significant Other Observable Inputs · Significant Other Unobservable Inputs | ||||
|---|---|---|---|---|
| As of December 31, 2024 | (Level 1) | (Level 2) | (Level 3) | Total |
| Assets | ||||
| Cash equivalents - Money market funds (1) | $54,925 | $— | $— | $54,925 |
| Mutual funds (2) | 108,251 | — | — | 108,251 |
| Derivative financial instruments | — | 2,825 | — | 2,825 |
| Total | $163,176 | $2,825 | $— | $166,001 |
| Liabilities | ||||
| Derivative financial instruments | $— | $11,817 | $— | $11,817 |
| Contingent consideration (3) | — | — | 2,700 | 2,700 |
| Total | $— | $11,817 | $2,700 | $14,517 |
| Quoted Prices in Active Markets for Identical Assets · Significant Other Observable Inputs · Significant Other Unobservable Inputs | ||||
|---|---|---|---|---|
| As of December 31, 2023 | (Level 1) | (Level 2) | (Level 3) | Total |
| Assets | ||||
| Cash equivalents - Money market funds (1) | $49,806 | $— | $— | $49,806 |
| Mutual funds (2) | 52,650 | — | — | 52,650 |
| Derivative financial instruments | — | 7,607 | — | 7,607 |
| Total | $102,456 | $7,607 | $— | $110,063 |
| Liabilities | ||||
| Derivative financial instruments | $— | $2,225 | $— | $2,225 |
| Contingent consideration (3) | — | — | 15,589 | 15,589 |
| Total | $— | $2,225 | $15,589 | $17,814 |
(1) Represents money market funds which are carried at the fair value option under ASC Topic 825 “Financial Instruments”.
(2) Represents those short-term investments which are carried at the fair value option under ASC Topic 825 “Financial Instruments”.
(3) Contingent consideration is presented under “Accrued Expenses and Other Current Liabilities” and “Other Non-Current Liabilities,” as applicable, in the consolidated balance sheets.
Fair Value of Derivative Financial Instruments:
The Company’s derivative financial instruments consist of foreign currency forward contracts and interest rate swaps. Fair values for derivative financial instruments are based on independent sources including highly rated financial institutions and are classified as Level 2. Refer to Note 17 - Derivatives and Hedge Accounting to the consolidated financial statements for further details.
Fair Value of Contingent Consideration:
The fair value measurement of contingent consideration is determined using Level 3 inputs. The Company’s contingent consideration represents a component of the total purchase consideration for business acquisitions. The measurement is calculated using unobservable inputs based on the Company’s own assessment of achievement of certain performance goals. The Company estimated the fair value of the contingent consideration based on the Monte Carlo simulation model.
The following table summarizes the changes in the fair value of contingent consideration:
| Year ended December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Opening balance | $15,589 | $18,689 |
| Acquisitions | 2,700 | — |
| Fair value changes | (589) | 1,900 |
| Payments | (15,000) | (5,000) |
| Closing balance | $2,700 | $15,589 |
During the years ended December 31, 2024 and 2023, there were no transfers among Level 1, Level 2 and Level 3.
Financial Instruments Not Carried at Fair Value:
The Company’s other financial instruments not carried at fair value consist primarily of cash and cash equivalents (except investments in money market funds, as disclosed above), short-term investments (except investments in mutual funds, as disclosed above), restricted cash, accounts receivable, net, long-term investments, accrued capital expenditures, accrued expenses, client liabilities and interest payable on borrowings for which fair values approximate their carrying amounts. The carrying value of the Company’s outstanding revolving credit facility approximates its fair value because the Company’s interest rate yield is near current market rates for comparable debt instruments.
- Derivatives and Hedge Accounting
The Company uses derivative instruments to mitigate cash flow volatility from risk of fluctuations in foreign currency exchange rates and interest rates. The Company enters into foreign currency forward contracts to hedge cash flow risks from forecasted transactions denominated in certain foreign currencies, and interest rate swaps to hedge cash flow risks from its revolving credit facility having variable interest rate obligations. These contracts qualify as cash flow hedges under ASC Topic 815, Derivatives and Hedging, and are with counterparties that are highly rated financial institutions.
The following table sets forth the aggregate notional amount of derivatives in cash flow hedging relationship:
| As of | ||
|---|---|---|
| December 31, 2024 | December 31, 2023 | |
| Foreign currency forward contracts denominated in: | ||
| Sell U.S. dollar (USD) | 984,300 | 722,800 |
| Interest rate swaps (Floating to fixed) denominated in: | ||
| USD | — | 75,000 |
The Company estimates that approximately $5,693 of derivative losses, net, excluding tax effects, included in AOCI, representing changes in the value of cash flow hedges based on exchange rates prevailing as of December 31, 2024, could be reclassified into earnings within the next twelve months. As of December 31, 2024, the maximum outstanding term of the cash flow hedges was approximately 45 months.
The Company also enters into foreign currency forward contracts to hedge its intercompany balances and other monetary assets and liabilities denominated in currencies other than functional currencies, against the risk of fluctuations in foreign currency exchange rates associated with remeasurement of such assets and liabilities to functional currency. These foreign currency forward contracts do not qualify as fair value hedges under ASC Topic 815, Derivatives and Hedging. Changes in the fair value of these financial instruments are recognized in the consolidated statements of income and are included in the foreign exchange gain/(loss) line item. The Company’s primary exchange rate exposure is with the Indian rupee (INR), the Philippine peso (PHP), the U.K. pound sterling (GBP) and South African rand (ZAR). The Company also has exposure to the Colombian peso (COP), the Euro (EUR), the Australian dollar (AUD), the Canadian dollar (CAD) and other local currencies in which it operates.
The following table sets forth the aggregate notional principal amounts of outstanding foreign currency forward contracts for derivatives not designated as hedging instruments:
| As of | ||
|---|---|---|
| Foreign currency forward contracts denominated in: | December 31, 2024 | December 31, 2023 |
| Sell USD | 179,491 | 170,543 |
| Sell GBP | 20,956 | 14,544 |
| Sell EUR | 9,008 | 5,231 |
| Sell AUD | 4,770 | 3,452 |
| Sell ZAR | 10,006 | 150,150 |
| Buy USD | 588 | — |
The following table sets forth the fair value of the foreign currency forward contracts and interest rate swaps and their location on the consolidated balance sheets:
| Derivatives in cash flow hedging relationships · Derivatives not designated as hedging instruments | ||||
|---|---|---|---|---|
| As of | As of | |||
| December 31, 2024 | December 31, 2023 | December 31, 2024 | December 31, 2023 | |
| Assets: | ||||
| Other current assets | $1,711 | $4,216 | $262 | $92 |
| Other assets | $852 | $3,299 | $— | $— |
| Liabilities: | ||||
| Accrued expenses and other current liabilities | $7,404 | $1,859 | $50 | $150 |
| Other non-current liabilities | $4,363 | $216 | $— | $— |
The following table sets forth the effect of foreign currency forward contracts and interest rate swaps on AOCI and the consolidated statements of income:
| Year ended December 31, | |||
|---|---|---|---|
| Derivative financial instruments: | 2024 | 2023 | 2022 |
| Unrealized gain/(loss) recognized in OCI | |||
| Derivatives in cash flow hedging relationships | $(14,513) | $14,403 | $(27,333) |
| Gain/(loss) recognized in consolidated statements of income | |||
| Derivatives not designated as hedging instruments | $(3,110) | $296 | $(9,571) |
The following table sets forth the location and amount of gain/(loss) recognized in consolidated statements of income for derivatives in cash flow hedging relationships and derivatives not designated as hedging instruments:
| Year ended December 31, | ||||||||
|---|---|---|---|---|---|---|---|---|
| 2024 · 2023 · 2022 | ||||||||
| As per consolidated statements of income · Gain/(loss) on derivative financial instruments · As per consolidated statements of income · Gain/(loss) on derivative financial instruments · As per consolidated statements of income · Gain/(loss) on derivative financial instruments | ||||||||
| Derivatives in cash flow hedging relationships | ||||||||
| Location in consolidated statements of income where gain/(loss) was reclassified from AOCI | ||||||||
| Cost of revenues | $1,147,359 | $(722) | $1,022,902 | $(5,180) | $896,595 | $(1,304) | ||
| General and administrative expenses | $225,672 | 110 | $198,294 | (454) | $169,016 | 141 | ||
| Selling and marketing expenses | $146,502 | 18 | $120,227 | (40) | $97,989 | 10 | ||
| Depreciation and amortization expense | $55,219 | 2 | $50,490 | (236) | $56,282 | (32) | ||
| Interest expense | $19,256 | 723 | $13,180 | 702 | $8,252 | (110) | ||
| Total before tax | 131 | (5,208) | (1,295) | |||||
| Income tax effects on above | (339) | 797 | (455) | |||||
| Net of tax | $(208) | $(4,411) | $(1,750) | |||||
| Derivatives not designated as hedging instruments | ||||||||
| Location in consolidated statements of income where gain/(loss) was recognized | ||||||||
| Foreign exchange gain/(loss), net | $891 | $(3,110) | $1,532 | $296 | $6,199 | $(9,571) | ||
- Borrowings
The following tables summarizes the Company’s debt position:
| As of | ||||||
|---|---|---|---|---|---|---|
| December 31, 2024 | December 31, 2023 | |||||
| Revolving credit facility | Term loan facility | Total | Revolving credit facility | Term loan facility | Total | |
| Current portion of long-term borrowings | $— | $5,000 | $5,000 | $65,000 | $— | $65,000 |
| Unamortized debt issuance costs | — | (114) | (114) | — | — | — |
| Total current portion of long-term borrowings | — | 4,886 | 4,886 | 65,000 | — | 65,000 |
| Long-term borrowings | 190,000 | 93,750 | 283,750 | 135,000 | — | 135,000 |
| Unamortized debt issuance costs | — | (152) | (152) | — | — | — |
| Total long-term borrowings | 190,000 | 93,598 | 283,598 | 135,000 | — | 135,000 |
| Total borrowings | $190,000 | $98,484 | $288,484 | $200,000 | $— | $200,000 |
Unamortized debt issuance costs for the Company’s revolving credit facility of $895 and $903 as of December 31, 2024 and 2023, respectively, are presented under “Other current assets” and “Other assets,” as applicable, in the consolidated balance sheets.
Credit Agreement
The Company held a $300,000 revolving credit facility pursuant to its credit agreement (the “Credit Agreement”), dated as of November 21, 2017 with certain lenders and Citibank N.A. as Administrative Agent, which was amended and restated on April 18, 2022 (the “2022 Credit Agreement”), Among other things, the 2022 Credit Agreement (a) provides for the issuance of new revolving credit commitments such that the aggregate amount of revolving credit commitments available as of April 18, 2022 to the Company is equal to $400,000; and (b) extends the maturity date of the revolving credit facility from November 21, 2022 to April 18, 2027.
On August 9, 2024, the Company and each of the Company’s wholly owned material domestic subsidiaries entered into a First Amendment to Amended and Restated Credit Agreement with Citibank, N.A., as Administrative Agent, and certain lenders (the “2024 Credit Agreement”), pursuant to which the parties thereto amended and restated the 2022 Credit Agreement. Among other things, the 2024 Credit Agreement (a) provides for a $100,000 increase to the revolving credit commitments such that the aggregate amount of revolving credit commitments available as of August 9, 2024 to the Company is equal to $500,000; and (b) provides for the issuance of a new term loan facility in the aggregate amount of $100,000 with an annual prepayment amount of 5%. The increased revolving credit facility and the new term loan facility both mature on April 18, 2027.
The 2024 Credit Agreement includes a letter of credit sub facility and is voluntarily pre-payable from time to time without premium or penalty. Borrowings under the revolving credit facility can be used for working capital and general corporate purposes, including permitted acquisitions. Borrowings of $100,000 under the term loan facility (which was drawn based on adjusted SOFR) were used to repay the borrowings outstanding under the revolving credit facility on August 9, 2024.
Obligations under the 2024 Credit Agreement are guaranteed by the Company’s wholly-owned material domestic subsidiaries and are secured by all or substantially all of the Company’s and its material domestic subsidiaries’ assets. The 2024 Credit Agreement contains customary affirmative and negative covenants, including, but not limited to, restrictions on the ability to incur indebtedness, create liens, make certain investments, make certain dividends and distributions, enter into, or undertake, certain liquidations, mergers, consolidations or acquisitions and dispose of certain assets or subsidiaries. In addition, the 2024 Credit Agreement contains a covenant to not permit the interest coverage ratio or the total net leverage ratio for the four consecutive quarter period ending on the last day of each fiscal quarter, to be less than 3.0 to 1.0 or more than 3.5 to 1.0, respectively.
The 2024 Credit Agreement bears interest at a rate equal to specified prime rate (alternate base rate) or adjusted SOFR, plus, in each case, an applicable margin. The applicable margin on the revolving credit facility is tied to the Company’s total net leverage ratio and ranges from 0% to 0.75% per annum on loans pegged to the specified prime rate, and 0.875% to 1.75% per annum on loans pegged to the adjusted SOFR. The applicable margin on the term loan facility is also tied to the Company’s total net leverage ratio and ranges from 0.125% to 1.00% per annum on loans pegged to the specified prime rate, and 1.125% to 2.00% per annum on loans pegged to the adjusted SOFR. The revolving credit commitments under the 2024 Credit Agreement are subject to a commitment fee which is also tied to the Company’s total net leverage ratio, and ranges from 0.125% to 0.275% per annum on the average daily amount by which the aggregate revolving commitments exceed the sum of outstanding revolving loans and letter of credit obligations.
The effective interest rates of the revolving credit facility and the term loan facility are as follows:
| Year ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Revolving credit facility | 6.3% | 6.3% | 2.9% |
| Term loan facility | 6.5% | —% | —% |
As of December 31, 2024 and 2023, the Company was in compliance with the financial covenants under the 2024 Credit Agreement.
The maturity profile of the Company’s long-term borrowings, excluding debt issuance costs, outstanding as of December 31, 2024 was as follows:
| Revolving credit facility · Term loan facility | ||
|---|---|---|
| 2025 | $— | $5,000 |
| 2026 | — | 5,000 |
| 2027 | 190,000 | 88,750 |
| Total | $190,000 | $98,750 |
Letters of Credit
In the ordinary course of business, the Company provides standby letters of credit to third parties primarily for facility leases. As of December 31, 2024 and 2023, the Company had outstanding letters of credit of $761 and $461, respectively, that were not recognized in the consolidated balance sheets.
- Capital Structure
Common Stock
The Company hasone class of common stock outstanding. Holders of the Company's common stock are entitled toone vote per share. Upon the liquidation or dissolution of the Company, its common stockholders are entitled to receive a ratable share of the available net assets of the Company after payment of all debts and other liabilities. The Company's shares of common stock have no preemptive, subscription, redemption or conversion rights.
Share Repurchases
The Company purchased shares of its common stock from certain employees in connection with withholding tax payments related to the vesting of restricted stock units and performance-based restricted stock units, as below:
| Shares repurchased | Total consideration | Weighted average purchase price per share (1) | |
|---|---|---|---|
| Twelve months ended December 31, 2024 | 303,836 | $10,266 | $33.79 |
| Twelve months ended December 31, 2023 | 237,047 | $7,853 | $33.13 |
| Twelve months ended December 31, 2022 | 164,080 | $4,121 | $25.12 |
(1) The weighted average purchase price per share is based on the closing price of the Company’s common stock on the Nasdaq Global Select Market on the trading day prior to the applicable vesting date of the restricted stock units.
On October 5, 2021, the Company’s board of directors authorized a $300,000 (excluding excise tax) common stock repurchase program beginning January 1, 2022 (the “2022 Repurchase Program”), and terminated the 2019 Repurchase Program on December 31, 2021.
On February 26, 2024, the Company’s board of directors authorized a $500,000 (excluding excise tax) common stock repurchase program beginning March 1, 2024 (the “2024 Repurchase Program”), and terminated the 2022 Repurchase Program on February 29, 2024.
On March 15, 2024, the Company entered into a 2024 ASR Agreement with Citibank to repurchase shares of its common stock for an aggregate purchase price of $125,000, as part of the Company’s 2024 Repurchase Program. Upon payment of the aggregate purchase price of $125,000, the Company received an initial delivery of 3,350,084 shares of its common stock at an initial price of $29.85 per share, representing 80% of the aggregate purchase price. The Company funded the repurchase with available cash on hand and borrowing from its revolving credit facility. The 2024 ASR Agreement was accounted for as a treasury stock transaction and forward stock purchase agreement indexed to the Company’s common stock. The forward stock purchase agreement was classified as an equity instrument under ASC Topic 815-40, Contracts in Entity's Own Equity, and deemed to have a fair value of zero at the effective date. The prepayment of $25,000 was initially recorded in additional paid-in capital, which reflected the pending settlement of the 2024 ASR Agreement. Under the terms of the 2024 ASR Agreement, the ultimate number of shares of Common Stock that the Company repurchased was based on the average of the daily volume-weighted average prices of the Common Stock during the term of the 2024 ASR Agreement, less a discount and subject to adjustments pursuant to the terms and conditions of the 2024 ASR Agreement.
On July 19, 2024, upon final settlement of the 2024 ASR Agreement, the Company received 820,433 additional shares of its common stock based on a daily volume-weighted average price of $29.97 per share during the term of the 2024 ASR Agreement. The additional shares received were recorded as treasury stock at a fair market value of $33.96 per share, and $2,862 was recorded in additional paid-in capital.
Under the Company’stwo repurchase programs, shares may be purchased by the Company from time to time from the open market and through private transactions, or otherwise, as determined by the Company’s management as market conditions warrant. Repurchases may be discontinued at any time by the management.
The Company purchased shares of its common stock, for a total consideration including commissions but excluding excise tax, under itstwo repurchase programs, as below:
| Shares repurchased | Total consideration | Weighted average purchase price per share | |
|---|---|---|---|
| Twelve months ended December 31, 2024 | 6,273,381 | $196,524 | $31.33 |
| Twelve months ended December 31, 2023 | 4,127,451 | $125,416 | $30.39 |
| Twelve months ended December 31, 2022 | 2,519,290 | $68,521 | $27.20 |
Repurchased shares have been recorded as treasury shares and will be held until the Company’s board of directors designates that these shares be retired or used for other purposes.
Pursuant to the Inflation Reduction Act, effective January 1, 2023, the Company is required to pay a 1% excise tax on the fair market value of each share of common stock repurchased, net of stock issuances. The Company recognized excise tax of $1,096 and $218 on repurchase of common stock as a part of cost of such repurchases for the years ended December 31, 2024 and 2023, respectively.
Dividends
The Company hasnot paid or declared any cash dividends on its common stock during the years ended December 31, 2024, 2023 and 2022. The Company’s borrowings under its revolving credit facility could restrict its ability to declare or make any dividends or similar distributions.
- Employee Benefit Plans
The Company’s Gratuity Plan in India (the “India Plan”) provides for a lump sum payment to vested employees on retirement or upon termination of employment in an amount based on the respective employee’s salary and years of employment with the Company. In addition, the Company’s subsidiary operating in the Philippines conforms to the minimum regulatory benefit, which provide for lump sum payment to vested employees on retirement from employment in an amount based on the respective employee’s salary and years of employment with the Company (the “Philippines Plan”). Liabilities with regard to the India Plan and the Philippines Plan are determined by actuarial valuation using the projected unit credit method. Current service costs for these plans are accrued in the year to which they relate. Actuarial gains or losses or prior service costs, if any, resulting from amendments to the plans are recognized and amortized over the remaining period of service of the employees.
The India Plan is partially funded whereas the Philippines Plan is unfunded. The Company makes annual contributions to the India Plan established with insurance companies. Fund managers manage these funds and calculate the annual contribution required to be made by the Company and manage the India Plan, including any required payouts. These funds are managed on a cash accumulation basis, inclusive of interest which is declared periodically. The Company earned a return of approximately 7.2% per annum on the India Plan for the year ended December 31, 2024.
The benefit obligation has been measured as of December 31, 2024 and 2023. The following table sets forth the activity and the funded status of the gratuity plans and the amounts recognized in the Company’s consolidated financial statements:
| Change in projected benefit obligation | 2024 | 2023 |
|---|---|---|
| Projected benefit obligation as of January 1 | $24,237 | $21,531 |
| Service cost | 4,429 | 3,799 |
| Interest cost | 1,552 | 1,569 |
| Benefits paid | (1,465) | (1,382) |
| Prior service cost | 2 | — |
| Acquisition adjustments | 398 | — |
| Actuarial loss/(gain) (1) | 1,546 | (1,166) |
| Effect of exchange rate changes | (845) | (114) |
| Projected benefit obligation as of December 31 | $29,854 | $24,237 |
| Change in plan assets | ||
| Plan assets as of January 1 | $17,134 | $14,449 |
| Actual return | 1,369 | 1,220 |
| Employer contribution | 3,353 | 2,913 |
| Benefits paid (2) | (1,338) | (1,343) |
| Effect of exchange rate changes | (555) | (105) |
| Plan assets as of December 31 | $19,963 | $17,134 |
| Unfunded status as of December 31 | $9,891 | $7,103 |
| Unfunded amount recognized in the consolidated balance sheets | ||
| Non-current liability (included under other non-current liabilities) | $9,555 | $6,925 |
| Current liability (included under accrued employee costs) | 336 | 178 |
| Total accrued liability | $9,891 | $7,103 |
| Accumulated benefit obligation as of December 31 | $20,181 | $16,655 |
| Plan assets in excess/(shortfall) of accumulated benefit obligation as of December 31 | $(218) | $479 |
(1) During the years ended December 31, 2024 and 2023, actuarial gain was driven by changes in actuarial assumptions, offset by experience adjustments on present value of benefit obligations.
(2) Benefits payments were substantially made through the plan assets during the years ended December 31, 2024 and 2023.
Components of net periodic benefit costs recognized in consolidated statements of income and actuarial (gain)/loss reclassified from AOCI, were as follows:
| Year ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Service cost | $4,429 | $3,799 | $3,770 |
| Interest cost | 1,552 | 1,569 | 1,232 |
| Expected return on plan assets | (1,237) | (1,048) | (872) |
| Amortization of actuarial (gain)/loss, gross of tax | (602) | (94) | 592 |
| Net gratuity cost | $4,142 | $4,226 | $4,722 |
| Amortization of actuarial (gain)/loss, gross of tax | $(602) | $(94) | $592 |
| Income tax effects on above | 33 | (74) | (179) |
| Amortization of actuarial (gain)/loss, net of tax | $(569) | $(168) | $413 |
The components of retirement benefits included in AOCI, excluding tax effects, were as follows:
| As of December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Net actuarial gain/(loss) | $(1,239) | $777 | $(462) |
| Net prior service cost | (4) | (5) | (8) |
| Amount recognized in AOCI, excluding tax effects | $(1,243) | $772 | $(470) |
The weighted average actuarial assumptions used to determine benefit obligations and net gratuity cost were:
| Year ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Discount rate | 6.9% | 7.1% | 7.3% |
| Rate of increase in compensation levels | 7.3% | 7.0% | 7.8% |
| Expected long-term rate of return on plan assets per annum | 7.3% | 7.3% | 7.3% |
The Company evaluates these assumptions annually based on its long-term plans of growth and industry standards. The discount rates are either based on current market yields on government securities or yields on government securities adjusted for a suitable risk premium, if available.
| Expected benefit payments during the year ending December 31, | |
|---|---|
| 2025 | $3,916 |
| 2026 | $3,943 |
| 2027 | $4,229 |
| 2028 | $3,657 |
| 2029 | $3,401 |
| 2030 to 2033 | $12,899 |
The Company maintains several 401(k) plans (the “401(k) Plans”) under Section 401(k) of the Internal Revenue Code of 1986, as amended (the “Code”), covering all eligible employees, as defined in the Code as a defined contribution plan. The Company may make discretionary contributions of up to a maximum of 3.0% of employee compensation within certain limits.
The Company’s contributions to various defined contribution plans was as follows:
| Year ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Contribution to the 401(k) Plans | $6,325 | $5,967 | $5,205 |
| Contributions to the defined contribution plans in foreign subsidiaries of the Company | $28,070 | $23,045 | $18,215 |
- Leases
The Company conducts its operations using facilities leased under operating lease agreements that expire at various dates. The Company finances its use of certain motor vehicles and other equipment under various lease arrangements provided by financial institutions. The lease agreements do not contain any covenants to impose any restrictions except for market-standard practice for similar lease arrangements.
The Company had performed an evaluation of its contracts with suppliers in accordance with ASC Topic 842, Leases, and had determined that, except for leases for office facilities, motor vehicles and other equipment as described above, none of the Company’s contracts contain a lease.
Supplemental balance sheet information
| As of | ||
|---|---|---|
| December 31, 2024 | December 31, 2023 | |
| Operating Lease | ||
| Operating lease ROU assets | $68,784 | $64,856 |
| Operating lease liabilities - Current | $16,491 | $12,780 |
| Operating lease liabilities - Non-current | 59,851 | 58,175 |
| Total operating lease liabilities | $76,342 | $70,955 |
| Finance Lease | ||
| Property and equipment, gross | $3,268 | $2,109 |
| Accumulated depreciation | (1,556) | (1,332) |
| Property and equipment, net | $1,712 | $777 |
| Finance lease liabilities - Current | $435 | $191 |
| Finance lease liabilities - Non-current | 1,349 | 613 |
| Total finance lease liabilities | $1,784 | $804 |
The components of lease cost, which are included in the Company’s consolidated statements of income, are as follows:
| Year ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Finance lease: | |||
| Depreciation on underlying ROU assets | $382 | $181 | $151 |
| Interest on lease liabilities | 196 | 90 | 59 |
| 578 | 271 | 210 | |
| Operating lease(1) | 21,764 | 20,188 | 21,783 |
| Variable lease costs | 4,490 | 4,374 | 5,033 |
| Sublease income | (122) | — | — |
| Total lease cost | $26,710 | $24,833 | $27,026 |
(1) Includes short-term leases, which are immaterial.
Supplemental cash flow and other information related to leases are as follows:
| Year ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Cash payments for amounts included in the measurement of lease liabilities : | |||
| Operating cash outflows for operating leases | $20,489 | $20,181 | $23,227 |
| Operating cash outflows for finance leases | $196 | $90 | $59 |
| Financing cash outflows for finance leases | $326 | $169 | $142 |
| ROU assets obtained in exchange for new operating lease liabilities | $20,518 | $24,880 | $734 |
| ROU assets obtained in exchange for new finance lease liabilities | $1,325 | $461 | $312 |
| Weighted average remaining lease term (in years) | |||
| Finance lease | 3.3 years | 3.1 years | 2.8 years |
| Operating lease | 4.9 years | 5.5 years | 5.9 years |
| Weighted average discount rate | |||
| Finance lease | 15.1% | 14.6% | 14.3% |
| Operating lease | 8.0% | 7.7% | 6.8% |
As part of the Company’s efforts to optimize its existing network of operations centers, the Company continued to evaluate its office facilities to determine where it can exit or consolidate its use of office space. The Company modified certain of its operating leases, resulting in an increase of its lease liabilities by $3,372 and $8,805, during the year ended December 31, 2024 and 2023, respectively, with a corresponding adjustment to ROU assets.
As of December 31, 2024 and 2023, the Company did not have any significant leases that have not yet commenced but that create significant rights and obligations for the Company.
There wasno impairment of ROU assets as of December 31, 2024 and 2023.
Maturities of lease liabilities as of December 31, 2024 were as follows:
| Operating Leases · Finance Leases | ||
|---|---|---|
| 2025 | $22,028 | $671 |
| 2026 | 20,434 | 631 |
| 2027 | 17,918 | 527 |
| 2028 | 15,191 | 353 |
| 2029 | 6,370 | 175 |
| 2030 and thereafter | 11,931 | — |
| Total lease payments | 93,872 | 2,357 |
| Less: Imputed interest | 17,530 | 573 |
| Present value of lease liabilities | $76,342 | $1,784 |
Maturities of lease liabilities as of December 31, 2023 were as follows:
| Operating Leases · Finance Leases | ||
|---|---|---|
| 2024 | $17,806 | $297 |
| 2025 | 16,878 | 256 |
| 2026 | 16,220 | 222 |
| 2027 | 13,712 | 191 |
| 2028 | 10,132 | 98 |
| 2029 and thereafter | 14,018 | — |
| Total lease payments | 88,766 | 1,064 |
| Less: Imputed interest | 17,811 | 260 |
| Present value of lease liabilities | $70,955 | $804 |
- Income Taxes
The components of income/(loss) before income taxes consist of the following:
| Year ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Domestic | $72,286 | $100,905 | $80,949 |
| Foreign | 189,061 | 137,036 | 109,150 |
| $261,347 | $237,941 | $190,099 | |
Income tax expense/(benefit) consists of the following:
| Year ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Current provision: | |||
| Domestic | $41,230 | $51,450 | $43,416 |
| Foreign | 41,591 | 33,828 | 23,701 |
| $82,821 | $85,278 | $67,117 | |
| Deferred provision/(benefit): | |||
| Domestic | $(19,172) | $(32,024) | $(17,624) |
| Foreign | (713) | 282 | (1,928) |
| (19,885) | (31,742) | (19,552) | |
| Income tax expense | $62,936 | $53,536 | $47,565 |
Deferred income taxes recognized in OCI were as follows:
| Year ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Deferred taxes benefit / (expense) recognized on: | |||
| Unrealized gain/(loss) on cash flow hedges | $2,559 | $(3,313) | $5,860 |
| Reclassification adjustment for cash flow hedges | 339 | (797) | 455 |
| Retirement benefits | 402 | (63) | (231) |
| Reclassification adjustment for retirement benefits | 33 | (74) | (179) |
| Currency translation adjustments | 3,129 | (156) | 10,032 |
| Total | $6,462 | $(4,403) | $15,937 |
The effective income tax rate differs from the amount computed by applying the U.S. federal statutory income tax rate to income before income taxes approximately as follows:
| Year ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Expected tax expense | $54,883 | $49,968 | $39,921 |
| Foreign tax rate differential | 1,164 | 5,333 | (1,136) |
| Unrecognized tax benefits | 704 | (187) | 273 |
| State taxes, net of Federal taxes | 10,724 | 11,640 | 7,730 |
| Non-deductible expenses | 10,330 | 8,655 | 10,087 |
| Excess tax benefit on stock-based compensation | (9,714) | (15,055) | (5,881) |
| Research and development credits | (5,257) | (5,350) | (2,733) |
| Others | 102 | (1,468) | (696) |
| Tax expense | $62,936 | $53,536 | $47,565 |
The effective tax rate increased from 22.5% during the year ended December 31, 2023 to 24.1% during the year ended December 31, 2024. The Company recorded income tax expense of $62,936 and $53,536 for the years ended December 31, 2024 and 2023, respectively. The increase in income tax expense was primarily as a result of higher profit, increase in non-deductible expenses and lower excess tax benefits related to stock-based compensation, partially offset by decrease in foreign tax rate differential during the year ended December 31, 2024 compared to the year ended December 31, 2023.
During the year ended December 31, 2024, some of the Company’s foreign subsidiaries repatriated $38,161 (net of $2,649 withholding taxes) to the United States. As of December 31, 2024, and December 31, 2023, accumulated net earnings generated by our foreign operations were approximately $658,454 and $546,828 respectively, of which $635,396 and $546,828 respectively, are indefinitely reinvested. Because most of the accumulated net earnings generated by our foreign operations has already been taxed for U.S. federal and state income tax purposes, any additional taxes due with respect to the repatriation of such earnings would generally be limited to the tax effect of currency gains or losses recognized on repatriation and foreign withholding taxes.
The components of the deferred tax balances were as follows:
| As of | ||
|---|---|---|
| December 31, 2024 | December 31, 2023 | |
| Deferred tax assets: | ||
| Tax credit carry forwards | $8,058 | $9,954 |
| Depreciation and amortization expense | 18,178 | 14,569 |
| Capitalized research and development expenses | 54,844 | 47,276 |
| Stock-based compensation | 10,902 | 8,506 |
| Accrued employee costs and other expenses | 33,897 | 21,670 |
| Net operating loss carry forwards | 281 | 212 |
| Net unrealized foreign exchange loss | 20,242 | 15,447 |
| Right-of-use assets | 20,125 | 19,042 |
| Others | 339 | 414 |
| 166,866 | 137,090 | |
| Valuation allowance | (3,172) | (482) |
| Deferred tax assets | $163,694 | $136,608 |
| Deferred tax liabilities: | ||
| Intangible assets | $29,883 | $27,095 |
| Net unrealized gain on investments | 4,018 | 3,704 |
| Capitalized costs | 7,665 | 5,999 |
| Lease liability | 16,586 | 16,188 |
| Others | 2,198 | 2,190 |
| Deferred tax liabilities | $60,350 | $55,176 |
| Net deferred tax assets | $103,344 | $81,432 |
Deferred tax assets and liabilities are recognized for future tax consequences attributable to temporary differences between the financial statement carrying values of assets and liabilities and their respective tax bases and operating loss carry forwards. The Company performed an analysis of the realizability of deferred tax assets as of December 31, 2024, and 2023, and recorded a valuation allowance of $3,172 and $482, respectively.
The Company has state research and development tax credit carryforwards as of December 31, 2024 of $4,083 (tax effected $3,226, net of federal benefit) that will expire by 2034, if not utilized. The Company has state net operating loss carryforwards as of December 31, 2024 of $5,515 (tax effected $281, net of federal benefit) of which $4,992 (tax effected $174, net of federal benefit) is allowed to be carried forward indefinitely and the balance will expire by 2039, if not utilized.
The Company’s income tax expense also includes provisions established for uncertain income tax positions determined in accordance with ASC Topic 740, Income Taxes. The Company monitors and adjusts these reserves in light of changing facts and circumstances. To the extent that the final tax outcome of these matters differs from the amounts recorded, such differences will impact the income tax expense in the period in which such determination is made.
The following table summarizes the activity related to the unrecognized tax benefits:
| Year ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Balance as of January 1 | $1,262 | $1,449 | $1,068 |
| Additions based on tax positions related to the current year | 561 | 423 | 223 |
| Additions based on tax positions of prior years | 316 | 112 | 158 |
| Reductions for tax positions due to lapse of statutes of limitations | (173) | (722) | — |
| Balance as of December 31 | $1,966 | $1,262 | $1,449 |
The unrecognized tax benefits as of December 31, 2024 of $1,966, if recognized, would impact the effective tax rate.
For the years ended December 31, 2024 and 2023, the Company hasnot accrued interest and penalties relating to unrecognized tax benefits.
- Stock-Based Compensation
On June 15, 2018, at the Company’s 2018 Annual Meeting of Stockholders, the Company's stockholders approved the 2018 Omnibus Incentive Plan, which among other things, reserves 15,875,000 shares of the Company’s common stock for grants of awards under the 2018 Omnibus Incentive Plan. As of December 31, 2024 and 2023, the Company had 1,813,592 and 4,096,102 shares, respectively, available for grant under the 2018 Omnibus Incentive Plan.
Under the 2018 Omnibus Incentive Plan, the Compensation and Talent Management Committee (the “Committee”) may grant awards of non-qualified stock options, incentive stock options, stock appreciation rights, restricted stock, restricted stock units, stock bonus awards, performance-based compensation awards (including cash bonus awards and market condition based awards) or any combination of the foregoing.
The Committee determines which employees are eligible to receive the equity awards, the number of equity awards to be granted, the exercise price, the vesting period and the exercise period. The vesting period for the equity award issued is determined on the date of the grant and is non-transferable during the life of the equity award. Stock options have a contractual period often years from the date of grant and vest ratably over four years. Restricted stock units generally vest proportionally over a period offour years from the date of grant, unless specified otherwise.
Stock-based compensation expense by nature of function, as below, are included in the consolidated statements of income:
| Year ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Cost of revenues | $15,762 | $14,686 | $11,535 |
| General and administrative expenses | 28,612 | 21,574 | 20,016 |
| Selling and marketing expenses | 28,284 | 22,177 | 17,815 |
| Total | $72,658 | $58,437 | $49,366 |
| Income tax benefit related to stock-based compensation (1) | $17,576 | $17,333 | $9,785 |
(1) Includes $9,714, $15,055 and $5,881 during the years ended December 31, 2024, 2023 and 2022, respectively, related to discrete benefits recognized in income tax expense in accordance with ASU No. 2016-09, Compensation - Stock Compensation.
Stock Options
Stock option activity under the Company’s stock-based compensation plans is shown below:
| Number of Options | Weighted Average Exercise Price | Aggregate Intrinsic Value | Weighted Average Remaining Contractual Life (Years) | |
|---|---|---|---|---|
| Outstanding as of December 31, 2023 | 1,790,695 | $30.14 | $1,278 | 9.5 |
| Granted | — | — | — | — |
| Exercised | (22,390) | 30.14 | 274 | — |
| Forfeited | — | — | — | — |
| Outstanding as of December 31, 2024 | 1,768,305 | $30.14 | $25,187 | 8.5 |
| Vested and exercisable as of December 31, 2024 | 425,265 | $30.14 | $6,058 | 8.5 |
| Weighted average grant date fair value of per unit of stock option granted during the period | $— | |||
Stock options were granted under the 2018 Omnibus Incentive Plan during the year ended December 31, 2023 which have a contractual period often years and vest ratably over four years.
The fair value of each stock option granted to employees is estimated on the date of grant using the Black-Scholes option-pricing model with the following assumptions:
| Year ended December 31, 2023 | |
|---|---|
| Dividend yield | — |
| Expected life (years) | 6.25 |
| Risk free interest rate for expected life | 3.8% |
| Volatility for expected life | 32.4% |
The Company does not anticipate paying any cash dividends in the foreseeable future and therefore uses an expected dividend yield of zero in the option valuation model.
As of December 31, 2024, unrecognized compensation cost of $13,326 is expected to be expensed over a weighted average period of 2.5 years.
The grant date fair value of stock options exercised and cash received from stock options exercised was as follows:
| Year ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Grant date fair value | $269 | $30 | $— |
| Cash received | $675 | $85 | $— |
Share Matching Program
Under the Company’s 2018 Omnibus Incentive Plan (the “2018 Plan”), the Company established a share matching program (“SMP”) for executive officers and other specified employees. Under the SMP, the Company agreed to issue a number of restricted stock units equal to the number of newly acquired shares of the Company's common stock. For purposes of the match, “newly acquired shares” includes the employee’s first quarter 2022 open market purchase of the common stock, and crediting of equity awards vesting under any existing stock award plan of the Company as having been purchased by such employees, in an amount between $100 to $500 per such employee.
The matching restricted stock units granted under the SMP will vest intwo installments, with one-third to vest on the second anniversary of the grant date and the remaining two-thirds to vest on the third anniversary of the grant date; the newly acquired shares for which the matching restricted stock units were granted must also be held by the employee until such vesting dates. The Company’s underlying common stock issued pursuant to the vesting of the matching restricted stock units will not be marketable or transferable for a period oftwo years following the vesting date. Certain forfeiture and other conditions apply.
Restricted stock unit activity under the SMP is shown below:
| Restricted Stock Units (SMP) | ||
|---|---|---|
| Number | Weighted AverageFair Value | |
| Outstanding as of December 31, 2023* | 217,230 | $24.95 |
| Granted | — | — |
| Vested* | (72,385) | 24.95 |
| Forfeited | — | — |
| Outstanding as of December 31, 2024* | 144,845 | $24.95 |
*As of December 31, 2024 and 2023 restricted stock units vested for which the underlying common stock is yet to be issued are 72,385 andnil, respectively.
As of December 31, 2024, unrecognized compensation cost of $445 is expected to be expensed over a weighted average period of 0.3 years.
Restricted Stock Units
The Committee is authorized to award restricted stock units to participants. The Committee establishes the terms, conditions and restrictions applicable to each award of restricted stock units, including the time or times at which restricted stock units will be granted or vested and the number of units to be covered by each award. The terms and conditions of each restricted stock award will be reflected in a restricted stock unit agreement.
Any cash or in-kind dividends paid with respect to unvested shares of restricted stock units are withheld by the Company and paid to the holder of such shares of restricted stock, without interest, only if and when such shares of restricted stock units vest. Any unvested shares of restricted stock units are immediately forfeited without consideration upon the termination of holder’s employment with the Company or its affiliates. Accordingly, the Company’s unvested restricted stock units do not include non-forfeitable rights to dividends or dividend equivalents and are therefore not considered as participating securities for purposes of earnings per share calculations pursuant to the two-class method.
Restricted stock unit activity under the Company’s stock-based compensation plans is shown below:
| Restricted Stock Units | ||
|---|---|---|
| Number | Weighted AverageFair Value | |
| Outstanding as of December 31, 2023* | 3,731,512 | $24.96 |
| Granted | 1,625,550 | 30.23 |
| Vested* | (1,818,180) | 22.26 |
| Forfeited | (298,682) | 28.22 |
| Outstanding as of December 31, 2024* | 3,240,200 | $28.82 |
*As of December 31, 2024 and 2023, restricted stock units vested for which the underlying common stock is yet to be issued are 289,547 and 324,125, respectively.
The fair value of restricted stock units is generally the market price of the Company’s shares on the date of grant. As of December 31, 2024, unrecognized compensation cost of $63,066 is expected to be expensed over a weighted average period of 2.6 years.
The weighted average fair value of restricted stock units granted and the grant date fair value of restricted stock units vested (including SMP) was as follows:
| Year ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Weighted average fair value of restricted stock units granted | $30.23 | $33.99 | $24.28 |
| Grant date fair value of restricted stock units vested | $42,279 | $33,058 | $24,002 |
Performance-Based Stock Awards
Under the 2018 Plan, the Company grants performance-based restricted stock units (“PRSUs”) to executive officers and other specified employees. During the year ended December 31, 2024, the Company granted 40% of each award recipient’s equity grants in the form of PRSUs that cliff vest at the end of athree-year period based on an aggregated revenue target for athree-year period (“PU”). The remaining 60% of each award recipient’s equity grants are PRSUs that are based on market conditions contingent on the Company's meeting the total shareholder return relative to a group of peer companies specified under the 2018 Plan, and are measured over athree-year performance period (“MU”).
The fair value of each PU is determined based on the market price of one common share on a day prior to the date of grant, and the associated stock compensation expense is calculated on the basis that performance targets at 100% are probable of being achieved. The stock compensation expense for the PUs is recognized on a straight-line basis over the service period, which is through the end of the third year. Over this period, the number of shares that will be issued are adjusted upward or downward based upon the probability of achievement of the performance targets. The final number of shares issued and the related compensation cost recognized as an expense is based on a comparison of the final performance metrics to the specified targets.
The grant date fair value for each MU is determined using a Monte Carlo simulation model and the related stock compensation expense is expensed on a straight-line basis over the vesting period. The stock compensation expense related to the MUs is recognized once the requisite performance period is fulfilled regardless of the extent of the market condition achieved.
The Monte Carlo simulation model simulates a range of possible future stock prices and estimates the probabilities of the potential payouts. This model also incorporates the following ranges of assumptions:
The historical volatilities are used over the most recent three-year period for the components of the peer group.
The risk-free interest rate is based on the U.S. Treasury rate assumption commensurate with thethree-year performance period.
Since the plan stipulates that the awards are based upon the TSR of the Company and the components of the peer group, it is assumed that the dividends get reinvested in the issuing entity on a continuous basis.
The correlation coefficients are used to model the way in which each entity tends to move in relation to each other are based upon the price data used to calculate the historical volatilities.
The fair value of each MU granted to employees is estimated on the date of grant using the following weighted average assumptions:
| Year ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Dividend yield | — | — | — |
| Expected life (years) | 2.9 | 2.9 | 2.9 |
| Risk free interest rate for expected life | 4.5% | 4.3% | 1.7% |
| Volatility for expected life | 29.9% | 32.9% | 38.3% |
PRSU activity under the Company’s stock plans is shown below:
| Revenue-Based PRSUs | Market Condition-Based PRSUs | |||
|---|---|---|---|---|
| Number | Weighted AverageFair Value | Number | Weighted AverageFair Value | |
| Outstanding as of December 31, 2023 | 438,000 | $29.16 | 656,450 | $37.78 |
| Granted | 344,535 | 28.91 | 516,692 | 42.11 |
| Adjustment upon final determination of level of performance goal achievement* | 213,435 | 24.00 | 319,975 | 31.13 |
| Vested** | (426,870) | 24.00 | (639,950) | 31.13 |
| Forfeited | (31,156) | 29.73 | (46,648) | 40.10 |
| Outstanding as of December 31, 2024 | 537,944 | $31.02 | 806,519 | $43.06 |
*Represents adjustment of shares vested in respect of PUs and MUs granted in 2022 upon achievement of the performance targets for such awards.
** Represents PUs and MUs vested for which the underlying common stock was issued subsequent to December 31, 2024.
As of December 31, 2024, unrecognized compensation cost of $33,943 is expected to be expensed over a weighted average period of 1.8 years.
Employee Stock Purchase Plan
On June 21, 2022, at the annual meeting of stockholders of the Company, the Company’s stockholders approved the ExlService Holdings, Inc. 2022 Employee Stock Purchase Plan (the “2022 ESPP”).
The 2022 ESPP allows eligible employees to purchase the Company’s shares of common stock through payroll deductions at a pre-specified discount to the lower of closing price of the Company’s common shares on the date of offering or the last business day of each purchase interval. The dollar amount of shares of common stock that can be purchased under the 2022 ESPP must not exceed 15% of the participating employee’s compensation during the offering period, subject to a cap of $25 per employee per calendar year. The Company has reserved 4,000,000 shares of common stock for issuance under the 2022 ESPP.
The fifth offering period under the 2022 ESPP commenced on July 1, 2024 with a term ofsix months.
Activity under the Company’s 2022 ESPP is shown below:
| Employee Stock Purchase Plan Unit’s | ||
|---|---|---|
| Number | Total Proceeds Received | |
| Shares available for issuance as of December 31, 2023 | 3,831,325 | |
| Issuance of common stock related to the: | ||
| Third offering period | 71,645 | $1,948 |
| Fourth offering period | 86,936 | $2,414 |
| Shares available for issuance as of December 31, 2024 | 3,672,744 | |
| Issuance of common stock related to the fifth offering period made subsequent to December 31, 2024 | 64,939 | $1,823 |
The ESPP is compensatory and results in compensation expense. The fair value of common stock to be issued under the ESPP was determined using the Black-Scholes option pricing model with the following assumptions:
| Fifth offering period ofJuly 1, 2024 to December 31, 2024 | Fourth offering period ofJanuary 1, 2024 to June 30, 2024 | Third offering period ofJuly 1, 2023 to December 31, 2023 | |
|---|---|---|---|
| Dividend yield | — | — | — |
| Expected life (years) | 0.5 | 0.5 | 0.5 |
| Risk free interest rate for expected life | 5.3% | 5.2% | 5.4% |
| Volatility for expected life | 25.5% | 30.1% | 25.5% |
| Discount for illiquidity | 7.4% | 7.5% | 8.9% |
- Related Party Disclosures
In April 2022, the Company entered into a service contract for providing analytics services to The Vanguard Group Inc., which reported that it beneficially owns approximately 10% of the Company’s common stock as of December 31, 2024. During the years ended December 31, 2024 and 2023, the Company recognized revenues, net of $638 and $1,975, respectively, related to this service contract. The Company had outstanding accounts receivable, net of $124 and $209 related to this service contract as of December 31, 2024 and 2023, respectively.
In February 2024, the Company entered into a service contract for providing analytics services to Corridor Platforms, Inc., which is an equity affiliate of the Company. During the year ended December 31, 2024, the Company recognized revenues, net of $424 related to this service contract. The Company had outstanding accounts receivable, net of $56 related to this service contract as of December 31, 2024.
- Commitments and Contingencies
Capital Commitments
As of December 31, 2024 and 2023, the Company had committed to spend approximately $6,500 and $7,100, respectively, under agreements to purchase property and equipment. This amount is net of capital advances paid which are recognized in consolidated balance sheets as “Capital work in progress” under “Property and equipment.”
On June 15, 2023, the Company, along with other limited partners, entered into a limited partnership agreement with the general partner, PNP Financial Services Fund GP I, LLC and initial limited partner and outgoing partner, to form a partnership with the name Plug and Play Financial Services Fund I, L.P. (the “Partnership”) for the primary purpose of making investments in growth-stage technology companies. During the year ended December 31, 2024, the Company further invested $600 in the Partnership and is committed under the Partnership to make further investments up to an amount of $2,800.
Other Commitments
Certain units of the Company’s Indian subsidiaries were established as 100% Export-Oriented units or under the Software Technology Parks of India or Special Economic Zone scheme promulgated by the Government of India. These units are exempt from customs, central excise duties, and levies on imported and indigenous capital goods, stores, and spares. The Company has undertaken to pay custom duties, service taxes, levies, and liquidated damages payable, if any, in respect of imported and indigenous capital goods, stores and spares consumed duty free, in the event that certain terms and conditions are not fulfilled. The Company believes, however, that these units have in the past satisfied, and will continue to satisfy, the required conditions.
The Company’s operations centers in the Philippines are registered as qualified Philippines Economic Zone Authority units, which provides the Company fiscal incentives on the import of capital goods and local purchase of services and materials. The Company is required to meet certain requirements to retain the incentives. The Company has complied and intends to continue compliance with the requirements to avail itself of the incentives.
Contingencies
The transfer pricing regulations in the countries where the Company operates require that controlled intercompany transactions be at arm’s-length. Accordingly, the Company determines and documents pricing for controlled intercompany transactions based on an economic analysis as prescribed in the respective regulations. The tax authorities have jurisdiction to review the Company’s transfer pricing. If the Company’s transfer pricing is challenged by the authorities, they could assess additional tax, interest and penalties, thereby impacting the Company’s profitability and cash flows.
The Company is currently involved in transfer pricing and related income tax disputes with Indian tax authorities. The aggregate amount demanded by Indian tax authorities (net of advance payments) as of December 31, 2024 and 2023 is $49,588 and $36,694, respectively. The Company has made payments and/or provided bank guarantees against these demands in the amounts of $7,506 and $7,227, as of December 31, 2024 and 2023, respectively. The Company believes that its positions will more likely than not be sustained upon final examination by the tax authorities, and accordingly has not accrued any liabilities with respect to these matters in its consolidated financial statements.
India’s VAT regime ended in June 2017 and was replaced by the current Goods and Service Tax (“GST”) regime. Pursuant to reviewing the Company’s annual VAT filings, the Indian tax authorities raised aggregate VAT demands for tax years 2015 and 2017, in the amounts of $5,339 and $5,493, as of December 31, 2024 and 2023, respectively. The Company has provided bank guarantees against these demands in the amounts of $5,339 and $4,570, as of December 31, 2024 and 2023, respectively. The GST authorities rejected the Company’s refunds claims in the amounts of $5,885 and $4,748 as of December 31, 2024 and 2023, respectively. The Company has filed appeals against these matters and believes that it is more likely than not that upon final examination its position will be sustained based on its technical merits. Accordingly, no provision was recognized as of December 31, 2024 and 2023, respectively.
Some of the Company’s subsidiaries in India have undergone assessments with the statutory authority with respect to defined contribution plan. Except for some components of the assessments for which the Company has recognized a provision in the financial statements, the Company believes that the amount demanded by such authority is not a meaningful indicator of the potential liabilities of the Company, and that these matters are without merit. The Company is defending against the assessment orders and in one case, has instituted an appeal against the order before the relevant tribunal while also making a payment under protest of the amount demanded. As of the reporting date, the Company’s management does not believe that the ultimate assessments in any of these matters will have a material adverse effect on the Company’s consolidated financial condition, results of operations or cash flows. The Company will continue to monitor and evaluate its position based on future events and developments on these matters.
From time to time, the Company, its subsidiaries, and/or their present officers or directors, may be or have been, named as a defendant in litigation matters, including employment-related claims. The plaintiffs in those cases seek damages, including, where applicable, compensatory damages, punitive damages and attorney’s fees. With respect to pending litigation matters as of the reporting date, the Company believes that the damages claimed are without merit, and the Company intends to vigorously defend them. The Company will continuously monitor developments on these matters to assess potential impacts to the financial statements.
The outcomes of legal actions are unpredictable and subject to significant uncertainties, and thus it is inherently difficult to determine the likelihood of the Company incurring a material loss or quantification of any such loss. With respect to certain pending litigation matters as of the reporting date, the Company has made provisions based on information currently available, including its evaluation of the facts underlying each matter and legal counsel’s advice on the estimated losses or range of reasonably possible losses. Based on the Company’s assessment, including the availability of insurance recoveries, the Company’s management does not believe that currently pending litigation, individually or in aggregate, will have a material adverse effect on the Company’s consolidated financial condition, results of operations or cash flows. The Company will continuously monitor these matters to assess potential impacts to the financial statements.
- Restructuring Costs
In second quarter of 2024, the Company initiated a strategic restructuring plan to align its workforce with market opportunities, business strategies and evolving customer needs. This plan was executed in the second quarter of 2024, which affected less than 1% of the Company’s global workforce.
The restructuring costs include costs in relation to employee severance and other associated costs including legal fees and outplacement support costs. These costs have been recognized under cost of revenues (across all reporting segments), general & administrative and selling & marketing expenses in the consolidated statements of income.
The following table summarizes the activity related to the restructuring costs incurred and paid during the year ended December 31, 2024:
| Year ended December 31, 2024 | |||
|---|---|---|---|
| Employee-Related Costs | Other Associated Costs | Total | |
| Opening balance | $— | $— | $— |
| Costs incurred during the period | 4,397 | 365 | 4,762 |
| Payments during the period | 4,397 | 365 | 4,762 |
| Closing balance | $— | $— | $— |
- Subsequent Event
In the first quarter of 2025, the Company began to implement operational and structural changes, resulting in the realignment of its reporting segments. The new reportable segments will be Insurance, Healthcare and Life Sciences, Banking, Capital Markets and Diversified Industries, and International Growth Markets. Beginning in the first quarter of 2025, the Company will reflect this change in segment presentation in its periodic and annual reports.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.